Acute & MSK · SCA case

Gout

NICE NG219 BSR 2017 SCA-ready

360 µmol/LULT target serum urate — all patients on allopurinol

300 µmol/LConsider as ULT target if tophi, chronic gouty arthritis or flares persist below 360

Offer ULTMultiple/troublesome flares, CKD 3–5, diuretics, tophi or chronic gouty arthritis (discuss with all)

AllopurinolFirst-line ULT; start low 50–100mg OD; titrate every 4 weeks

DO NOTStop established allopurinol during a flare; start new ULT 2–4 weeks after it settles (sooner only with anti-inflammatory cover if flares are frequent)

ColchicineOne first-line flare option with an NSAID or short oral steroid — choose by comorbidity (500mcg BD–TDS; max 6mg/course)

HLA-B*5801Screen before allopurinol in Han Chinese, Thai, Korean ancestry

eGFRStart allopurinol lower and titrate more slowly in CKD — CKD is not a bar to reaching target

📋 Clinical Stem — Gout Presentation

A patient presents with an acutely painful, hot, swollen joint — or with a known history of gout seeking advice about recurrent flares or long-term urate-lowering therapy — requiring systematic assessment to confirm the diagnosis, exclude septic arthritis, address modifiable triggers, and initiate evidence-based acute and preventive management.

"Mr Patel, 54 years old, attends as an urgent appointment. He woke at 3 am with severe pain, redness, and swelling in his right big toe. He describes the pain as the worst he has ever experienced — he cannot bear the bedsheet touching it. He has had two similar episodes in the last 18 months. He takes bendroflumethiazide for hypertension and drinks approximately 20 units of alcohol per week, mostly beer. He is worried it is 'something to do with his blood.' His wife has told him it is gout but he is not sure what that means or what to do about it."

Gout presentations range from a classic first metatarsophalangeal (MTP) attack in a middle-aged man to polyarticular gout in a woman on diuretics, to an atypical presentation in a patient with CKD or organ transplant. The SCA scenario may present as an acute flare, a request for long-term management, concerns about allopurinol, or a patient wanting to know whether they can stop urate-lowering therapy. The framework applies to all presentations.

Scenario A — Classic first acute flare 52yo man, sudden onset severe pain and swelling right first MTP joint, 3 am onset, self-limiting in previous episodes. First presentation seeking diagnosis and treatment. Needs education about the condition and discussion of ULT eligibility.

Scenario B — Recurrent flares on no treatment 58yo woman, 3 flares in 12 months, currently on diuretics for heart failure. NICE NG219 mandates ULT offer. Needs medication review (thiazide diuretics worsen gout) and allopurinol initiation with colchicine prophylaxis.

Scenario C — Allopurinol concern / non-adherence 61yo man, stopped allopurinol after reading online it "causes flares." Serum urate elevated at 520 µmol/L. Needs education about the paradoxical flare risk of starting/stopping, importance of continuing, and monitoring schedule.

Scenario D — Possible septic arthritis 67yo immunosuppressed patient (azathioprine post-renal transplant), acutely hot swollen knee. Cannot distinguish gout from septic arthritis clinically. Requires same-day joint aspiration and orthopaedics referral — never assume gout.

Scenario E — Gout with CKD 63yo with CKD stage 3, eGFR 42, recurrent gout. Allopurinol dose requires CKD adjustment. Febuxostat is an alternative (use cautiously in major cardiovascular disease per current MHRA advice). Colchicine dose adjustment needed for CKD.

Key variables to adapt for: Joint affected (classic 1st MTP vs. atypical — ankle, knee, wrist, polyarticular); sex (women present later, often on diuretics); renal function (dose adjustments critical); immunosuppression (septic arthritis risk higher); ethnicity (HLA-B*5801 screening before allopurinol in East/Southeast Asian ancestry); trigger identification (alcohol, diet, medications, dehydration).

Steps:

Step 1

History Taking — Open Question First · Targeted Questions · ICE · Psychosocial Context

▲collapse

The gout history has four simultaneous objectives: characterise the joint attack (onset, joint(s), severity, duration, prior episodes), exclude the surgical emergency of septic arthritis — which can be clinically identical to gout, identify modifiable triggers and perpetuating medications, and determine ULT eligibility based on NICE NG219 criteria (frequency, tophi, comorbidities, renal function). The 3 am onset of maximal pain in the first MTP joint is pathognomonic for gout — but never let classic features prevent you from excluding septic arthritis.

🎓 Consultation opener — use existing information first

"I can see you've come in urgently about a very painful joint — it sounds like it's been a really difficult night. Can you tell me what's been happening in your own words?"

Gout pain is notoriously severe and distressing — acknowledging this validates the patient's experience and creates a therapeutic alliance. Starting with "tell me in your own words" allows the characteristic gout narrative (3 am onset, extreme tenderness, inability to bear weight) to emerge naturally, which is both diagnostically informative and gives the patient permission to express the distress that a condition this painful invariably causes.

1A — Start with an open question: let the patient lead, then move to targeted questions

Question to ask	Why it matters clinically	Changes what?
🟢 OPEN QUESTION — always start here"Tell me what's been happening — what's the pain been like and how did it start?"	The characteristic gout narrative — nocturnal onset, rapid escalation to maximal pain, extreme tenderness (unable to bear bedsheet touching the joint), single joint, red and swollen — emerges spontaneously when the patient is given space to describe the experience. This narrative is diagnostically specific and saves time by rendering most targeted questions confirmatory rather than exploratory.Scores: Global Skills (patient-centredness), Tasks (efficient data gathering), Relating to Others (acknowledgement of suffering).	DDxRx planPsychosocial
Onset and time course"When exactly did it start? Did it come on suddenly — overnight — or gradually?"	Gout classically reaches maximal intensity within 12–24 hours of onset — often waking the patient from sleep at 3–4 am. This rapid nocturnal onset is characteristic: urate crystals precipitate in cooler peripheral joints during sleep when body temperature drops and urate solubility decreases. A gradual onset over days or weeks is more consistent with septic arthritis, rheumatoid, or reactive arthritis.Sudden 3 am maximal onset strongly supports gout; gradual onset → broaden DDx and consider joint aspiration urgently.	DDx
Joint(s) affected"Which joint or joints are affected? Is it one joint or several?"	Gout most commonly affects the first metatarsophalangeal (MTP) joint (podagra — present in ~70% of first attacks). Other common joints: ankle, midfoot, knee, wrist, and olecranon bursa. Polyarticular involvement is seen in severe or long-standing gout, particularly in women on diuretics. A single hot swollen large joint (knee, ankle, wrist) warrants same-day aspiration to exclude septic arthritis regardless of the history.Podagra = strongly supports gout; single large joint = joint aspiration to exclude septic arthritis; polyarticular = consider rheumatoid, reactive, or psoriatic arthritis in DDx.	DDxReferral
Previous episodes"Have you had anything like this before? How many episodes have you had in the past year or two?"	The number of previous episodes directly shapes ULT eligibility. NICE NG219: offer treat-to-target ULT to people with multiple or troublesome flares, CKD stages 3–5, long-term diuretic therapy, tophi or chronic gouty arthritis, and discuss ULT with everyone after a first or subsequent flare. Establish a clear timeline of episodes — many patients have had multiple episodes dismissed as "sprains."Multiple or troublesome flares → offer ULT today; first episode → discuss ULT and plan review.	DDxRx
Severity and functional impact"On a scale of 1 to 10, how severe is the pain? Can you walk on it? Can you bear the bedsheet touching it?"	Gout is one of the most painful conditions in medicine — patients often describe it as the worst pain of their life. The extreme tenderness (allodynia — pain from non-noxious stimuli like a bedsheet) is characteristic and diagnostically helpful. It also establishes baseline severity for monitoring treatment response, and quantifying the disability justifies a fit note if needed.Extreme allodynia (unable to bear bedsheet) is characteristic of acute gout and distinguishes it from less severe acute arthritides.	DDxRx
Systemic features — fever, rigors, unwell"Have you had a fever, chills, or felt generally unwell with this episode?"	This is the most critical discriminating question. Fever and systemic illness occur in both gout and septic arthritis — but their presence significantly increases the urgency for joint aspiration and same-day orthopaedic or rheumatology assessment. A temperature above 38°C with a hot swollen joint = treat as septic arthritis until proven otherwise, even if a history of gout is known.Fever + hot swollen joint = septic arthritis until proven otherwise by joint aspiration; temperature >38°C → same-day referral regardless of prior gout history.	UrgencyDDxReferral
Dietary triggers"In the 24–48 hours before this started, did you eat anything different — a lot of red meat, shellfish, offal? Did you have a big meal or a celebration?"	High-purine foods (red meat, organ meats, shellfish, anchovies, sardines) cause rapid rises in serum urate and can precipitate acute flares. Identifying the trigger both explains the episode to the patient and informs dietary advice. Fructose-sweetened drinks (especially fruit juice and fizzy drinks) also raise urate independently of purine content via hepatic metabolism.Dietary trigger identified → specific dietary advice and motivational framing ("if we can address this, we may prevent the next episode").	LifestylePsychosocial
Alcohol"How much alcohol have you been drinking recently — especially beer or spirits? Was there any particular drinking in the days before this episode?"	Alcohol is the most important modifiable risk factor for gout. Beer and spirits (but less so wine) are particularly high-purine and also directly inhibit renal urate excretion. Even a single heavy drinking episode ("a big night out") can precipitate an acute flare by raising serum urate acutely. Quantifying alcohol intake is essential both for trigger identification and for overall management — alcohol reduction alone can reduce flare frequency significantly.Alcohol intake >14 units/week is a major gout risk factor; AUDIT-C screen; reduction advice is a core management component.	Rx + LifestylePsychosocial
Medications — diuretics, aspirin, ciclosporin"Are you on any water tablets? What blood pressure or heart medications are you taking? Any aspirin? Any immunosuppressants?"	Thiazide and loop diuretics are among the most common iatrogenic causes of gout — they reduce renal urate excretion, raising serum urate. Low-dose aspirin has the same effect. Ciclosporin and tacrolimus dramatically raise urate. If the patient is on a thiazide for uncomplicated hypertension, switching to an ARB (losartan) is an active management option — losartan has a mild uricosuric effect. This medication review is a core SCA task.Thiazide diuretic for uncomplicated hypertension → consider switching to losartan ARB (mild uricosuric + antihypertensive); loop diuretic for heart failure → cannot stop; manage gout alongside.	DDxRx
Kidney stones / urinary symptoms"Have you ever had kidney stones or blood in your urine?"	Uric acid nephrolithiasis occurs in approximately 20% of patients with gout. Urate stones are a strong reason to discuss and offer ULT even after a first flare (the NICE NG219 offer criteria are multiple or troublesome flares, CKD 3–5, diuretic therapy, tophi or chronic gouty arthritis). Hyperuricaemia causes both nephrolithiasis and uric acid nephropathy (contributing to CKD). Establishing this link contextualises the systemic nature of the condition for the patient.History of kidney stones → discuss and offer ULT even after a first flare; check eGFR and urine dipstick.	DDxRx
Tophi — visible deposits, ear cartilage, fingers"Have you ever noticed any hard lumps on your ear cartilage, knuckles, elbows, or around affected joints?"	Tophi are deposits of monosodium urate crystals in soft tissue — pathognomonic of chronic tophaceous gout and a definitive diagnostic marker. Their presence indicates prolonged hyperuricaemia and is an absolute NICE NG219 indication for ULT. Tophi can ulcerate and become infected; over joints they can damage cartilage and bone. Patients often notice them but do not know their significance.Tophi present → NICE NG219: offer ULT; consider a lower target below 300 µmol/L to dissolve existing tophi.	DDxRx
Comorbidities — CKD, cardiovascular, diabetes, obesity"Do you have any kidney problems or have you had any kidney function tests recently? Do you have heart problems, diabetes, or high blood pressure?"	Gout is strongly associated with the metabolic syndrome cluster: hypertension, CKD, type 2 diabetes, and cardiovascular disease. CKD affects allopurinol dosing (must be adjusted for eGFR) and colchicine safety (contraindicated in severe CKD, GFR <10). Gout itself is an independent cardiovascular risk factor — each flare may reflect systemic hyperuricaemia contributing to endothelial damage.CKD → allopurinol dose reduction by eGFR; renal transplant + immunosuppression → same-day aspiration to exclude septic arthritis; metabolic syndrome → comprehensive cardiovascular risk review.	DDxRx

1B — Red flags: must not miss · must ask · must act

🚨

Red Flags — act before continuing history

Red flag	Why dangerous	Action
Hot swollen joint + fever (>38°C) + systemically unwell	Septic arthritis is the most feared mimic of gout and is a surgical emergency. Delay to diagnosis and joint washout risks permanent joint destruction, osteomyelitis, and septicaemia. Gout and septic arthritis can coexist in the same joint. Fever does not exclude gout but cannot exclude septic arthritis — joint aspiration is the only way to differentiate.	Same-day joint aspiration + orthopaedics/rheumatology
Hot swollen joint in an immunosuppressed patient (transplant, steroids, biological agents, chemotherapy)	Immunosuppressed patients have dramatically higher risk of septic arthritis from organisms that would not cause joint infection in immunocompetent hosts. The usual systemic inflammatory response may be blunted, making clinical distinction from gout even harder. Do not rely on typical gout features in this population.	Same-day joint aspiration + infectious disease / orthopaedics
Rapidly spreading cellulitis or erythema beyond the joint	Cellulitis complicating or mimicking gout can be misdiagnosed as the joint inflammation of gout itself. Spreading cellulitis with a red line (lymphangitis) or rapidly expanding erythema indicates bacterial soft tissue infection requiring IV antibiotics and inpatient admission. The risk of necrotising fasciitis exists in severe cases.	Same-day A&E if lymphangitis or rapidly spreading
Signs of systemic sepsis with joint inflammation (tachycardia, hypotension, confusion)	Septic arthritis causing haematogenous spread can progress to frank sepsis with haemodynamic compromise. Any patient with a hot joint and cardiovascular or neurological compromise needs emergency assessment and likely IV antibiotics.	999 / A&E immediately
First presentation of hot joint in a child or young adult (<30 years)	Primary gout is extremely rare in pre-menopausal women or men under 30. A hot swollen joint in this age group should prompt consideration of: septic arthritis, reactive arthritis (sexually acquired — Chlamydia), haemophilia or other haematological cause, pseudogout (CPPD), or secondary gout from an underlying metabolic disease (enzyme deficiency, lymphoproliferative disorder). Screen for STIs if sexually active and young.	Urgent investigation; STI screen if young adult; rheumatology referral
Rapidly progressive polyarthritis with systemic features	Acute polyarticular flare with fever and systemic symptoms may represent acute rheumatoid arthritis presenting as a flare, viral arthritis (parvovirus B19, hepatitis B), reactive arthritis, or very rarely Still's disease. These all require urgent specialist assessment.	Urgent rheumatology referral within 2 weeks

🛡️

Safeguarding Considerations — Consider in Every Consultation

Gout rarely presents in a safeguarding context directly, but the consultation creates an opportunity to assess factors that may indicate harm or vulnerability. Alcohol use is the most important modifiable risk factor for gout — it is also a major driver of domestic abuse, child neglect, and self-harm. A patient with recurrent gout and escalating alcohol use may be experiencing domestic violence or significant social adversity.

🍺 Alcohol Use and Dependence

Quantify alcohol intake using AUDIT-C at every gout consultation
Heavy alcohol use is the strongest modifiable risk factor for gout recurrence
Alcohol dependence may indicate neglect of dependent children or vulnerable adults
Brief intervention for hazardous drinking (FRAMES) appropriate; refer to drug and alcohol service if dependent

🏠 Domestic Abuse and Social Circumstances

Recurrent gout flares without compliance with management may reflect social adversity, inability to afford healthy food, or unsafe living conditions
If injuries noted alongside joint presentation, consider whether trauma has been disclosed accurately
Patients presenting repeatedly in crisis without engaging with long-term management — consider whether there are social barriers to engagement

👴 Older Adults and Frailty

Gout in a frail older adult may represent polypharmacy-driven hyperuricaemia (multiple diuretics, low-dose aspirin)
Severe gout pain in an older adult with limited mobility may indicate carer stress or inability to manage at home
Review social support and carer capacity when managing severe acute gout in frail patients

💊 Medication Concerns and Self-Harm

Patients requesting large supplies of colchicine — note that colchicine is highly toxic in overdose (multi-organ failure)
Be aware of suicide risk in the context of chronic pain and depression — gout and recurrent flares may worsen mood significantly
Medication misuse risk: colchicine toxicity is potentially fatal at relatively small overdoses

If a safeguarding concern is identified: Address alcohol use with the AUDIT-C tool and a brief intervention at every consultation — this is both clinical best practice and may address underlying safeguarding risks. For domestic violence concerns, enquire sensitively when the patient is alone. For concerns about vulnerable adults or children in the household, use the practice safeguarding lead and make a MASH referral if indicated. Colchicine should be prescribed in appropriate quantities only.

1C — PMH · FH · Drug history · Social history: management impact

🧬 PMH / FH — changes management

Factor	Why it matters	Management impact
Chronic kidney disease (CKD)	Reduces renal urate excretion (worsens gout); allopurinol and colchicine require dose adjustment; colchicine contraindicated in severe CKD (eGFR <10)	Allopurinol: start 50mg OD and titrate more slowly in CKD; colchicine: halve dose in CKD stage 3b–5; febuxostat: preferred when allopurinol not tolerated in CKD
Cardiovascular disease (IHD, HF, stroke)	Gout is an independent cardiovascular risk factor; MHRA advises using febuxostat cautiously in pre-existing major cardiovascular disease; NICE recommends allopurinol first-line here	Allopurinol preferred over febuxostat in patients with established CVD; address modifiable CVD risk factors alongside gout (hypertension, dyslipidaemia, obesity)
Organ transplant (renal, cardiac, liver)	Ciclosporin dramatically raises serum urate; azathioprine + allopurinol combination is potentially fatal (allopurinol inhibits xanthine oxidase → toxic azathioprine metabolite accumulation)	NEVER combine allopurinol (or febuxostat, also a xanthine oxidase inhibitor) with azathioprine without specialist input; dose adjustments complex — rheumatology or transplant team should lead ULT
Type 2 diabetes / metabolic syndrome	Insulin resistance reduces renal urate excretion; obesity raises urate via increased purine synthesis; part of the metabolic syndrome cluster with gout	Address metabolic syndrome comprehensively; weight loss reduces serum urate and flare frequency; SGLT2 inhibitors have uricosuric effect — discuss if T2DM co-present
Hypertension	Thiazide diuretics are among the most common iatrogenic causes of gout; losartan ARB is antihypertensive with mild uricosuric effect — preferred switch option	If on bendroflumethiazide for uncomplicated hypertension → switch to losartan; if on thiazide for heart failure → cannot switch; manage gout alongside diuretic
Family history of gout	Strong genetic component (SLC22A12, ABCG2 transporters); family history predicts early-onset gout and higher recurrence rate	Lower threshold for initiating ULT; genetic counselling context if family history of early-onset severe gout; consider enzyme deficiency testing if very young age at onset
History of kidney stones	Uric acid nephrolithiasis in 20% of gout patients; a strong reason to offer ULT after even a single flare	ULT should be offered after even the first flare if kidney stones present; adequate hydration advice; alkalinisation of urine may help prevent stone recurrence
Haematological malignancy / tumour lysis syndrome risk	High cell turnover causes massive purine release → acute urate nephropathy; gout can be the presenting feature of undiagnosed lymphoma or polycythaemia	FBC to exclude polycythaemia vera or lymphoma if young age, very high urate, polyarticular gout, or unexplained cytopenias; haematology referral if suspected

💊 Drug history · Social history — clinical impact

Factor	Why it matters	Management impact
Thiazide diuretics (bendroflumethiazide, indapamide)	Reduce renal urate excretion — the most common drug cause of secondary gout in primary care; the dose-urate relationship is linear	If for uncomplicated hypertension → switch to losartan; if for heart failure → cannot stop; offer ULT (diuretic therapy is a NICE NG219 criterion)
Loop diuretics (furosemide, bumetanide)	Similar effect to thiazides on urate excretion; often prescribed for heart failure — cannot stop	Cannot switch; offer ULT (diuretic therapy is a NICE NG219 criterion); ensure adequate hydration in ambulant patients
Low-dose aspirin (75–150mg)	Low-dose aspirin reduces renal urate excretion (paradox: high-dose aspirin is uricosuric); cannot stop if cardiovascular indication	Do not stop aspirin for gout; initiate ULT if gout meets criteria; explain to patient why aspirin cannot be stopped
Ciclosporin / tacrolimus (transplant immunosuppression)	Dramatically raise serum urate; gout is extremely common in renal transplant recipients on ciclosporin	Coordinate ULT with transplant team; allopurinol + azathioprine combination is potentially fatal; febuxostat also interacts with azathioprine — specialist-led ULT
Pyrazinamide / ethambutol (TB treatment)	Both reduce renal urate excretion; gout can be precipitated during TB treatment	Manage with colchicine or NSAIDs acutely; ULT usually not needed as TB treatment course is time-limited; coordinate with TB team
Diet — red meat, shellfish, offal, fructose drinks	High-purine foods directly raise serum urate; fructose (fruit juice, fizzy drinks) raises urate via hepatic metabolism independently of purine content	Advise a healthy, balanced diet and avoid sugar-sweetened drinks; do not prescribe a restrictive gout diet (NICE found insufficient evidence that any specific diet lowers urate)
Dehydration	Reduces renal urate excretion; concentrates urate in tissues; hot weather or exercise without adequate hydration can precipitate attacks	Encourage adequate hydration unless contraindicated (individual advice in heart failure, CKD or fluid restriction) — no universal fluid volume
Alcohol (especially beer, spirits)	Beer is particularly goutogenic: high purine content + ethanol inhibits urate excretion + dehydration. Even a single large intake can precipitate a flare	AUDIT-C screen; advise reducing to <14 units/week; beer particularly to be reduced; brief intervention; drug and alcohol service if dependent

1D — ICE: Ideas · Concerns · Expectations — in every consultation, not just SCA

Gout is one of the most manageable chronic conditions in medicine — yet adherence to long-term urate-lowering therapy is notoriously poor, largely because of patient misconceptions. Patients believe gout is a dietary problem they can solve themselves; they think allopurinol causes the flares that sometimes accompany initiation; they do not understand that the goal is to treat a chronic metabolic disease rather than just suppress attacks. Without exploring these beliefs and concerns explicitly, the GP cannot deliver an effective explanation, and the patient will likely not take allopurinol long-term.

💭 Ideas

"What do you think is causing these episodes? Have you any idea what gout actually is — what's happening in the joint?"

Most patients have an entirely inaccurate model of gout — "too much rich food," "a lifestyle disease," or "something only old men get." Very few understand that gout is a systemic metabolic condition caused by chronic hyperuricaemia leading to urate crystal deposition. Without correcting this model, patients may believe that dietary modification alone is sufficient, and will refuse or discontinue allopurinol unnecessarily.

😟 Concerns

"Is there anything about this that particularly worries you — or about any treatment we might discuss today?"

Common hidden concerns: fear that gout indicates kidney disease or cancer ("something in my blood"); fear that allopurinol will "cause more gout flares" (partially true — initiation can trigger flares without prophylaxis, which must be explained); concern about long-term medication use; stigma about gout being seen as a self-inflicted disease of excess. Each concern requires a specific, targeted response — the allopurinol flare concern in particular will derail treatment if not addressed proactively.

🎯 Expectations

"What were you hoping we would be able to do for you today — just get rid of this attack, or is there something longer-term you were wondering about?"

Most patients attending with an acute flare want the pain relieved today — they are often not ready to have a long-term disease management conversation during the acute episode. This expectation must be acknowledged: acute pain relief is the priority. However, the consultation should also plant the seed for a follow-up discussion about ULT — "once this settles, I'd like to see you back to talk about how we prevent this happening again." Managing both the immediate and long-term expectations in the same consultation is an SCA Global Skills mark.

1E — Psychosocial context: the person behind the gout

Gout is not merely a joint disease — it is the visible manifestation of a metabolic syndrome cluster involving hyperuricaemia, hypertension, dyslipidaemia, obesity, CKD, and insulin resistance. The lifestyle factors that drive hyperuricaemia (diet, alcohol, physical inactivity) are embedded in social and cultural contexts. Effective long-term management requires understanding those contexts — not blaming the patient for them.

🍺 Alcohol Culture and Social Context

Alcohol consumption — particularly beer — is the most powerful modifiable risk factor for gout recurrence. For many patients, drinking is deeply embedded in their social identity, occupational culture (building trades, agriculture, hospitality), or is a coping mechanism for stress.

"I can see that cutting down on beer would be a significant change — can you tell me a bit about how central that is to your social life and work, so I can understand what would actually be realistic for you?"

Non-judgmental quantification and brief motivational intervention; link alcohol reduction directly to reduced flare frequency as a motivational frame.

🍽️ Diet and Food Access

Dietary modification for gout requires access to affordable low-purine protein sources. Advice to "reduce red meat and eat more fish" can be economically challenging for patients in food poverty. Shellfish, offal, and processed meat may form a significant proportion of a patient's diet for financial reasons.

"We've talked about some dietary changes — I want to make sure the advice I'm giving you is actually achievable with your shopping budget and cooking situation. Is there anything that might make it difficult to follow?"

Social prescribing referral if food access is a barrier; dietitian referral for complex dietary management; avoid victim-blaming framing.

😤 Stigma and Self-Blame

Gout carries a significant cultural stigma — it has historically been characterised as a disease of gluttony and excess. Many patients feel deeply embarrassed and blame themselves entirely for the condition. This shame delays presentation, reduces adherence, and prevents open discussion of the lifestyle factors contributing to the disease.

"I want to say clearly that gout is a medical condition, not a moral failing. There are genetic and physiological factors at play, not just lifestyle. Plenty of people who live very healthily still get gout."

Destigmatising gout explicitly improves treatment adherence and patient engagement. Normalising the condition as metabolic rather than moral changes the therapeutic relationship.

💼 Occupational Impact and Sick Leave

Acute gout flares can be severely disabling — patients who work in manual occupations (construction, driving, agriculture) may be unable to work during a flare. For self-employed patients, inability to work has direct financial consequences. Chronic tophaceous gout can cause permanent disability.

"This attack sounds like it's affecting your ability to work — is that something we need to think about? I can provide a fit note if you need time off to manage this."

Fit note appropriate for severe acute gout; framing ULT as "preventing future episodes that stop you working" is a powerful motivational tool for occupationally active patients.

⚕️ Medication Reluctance and Health Beliefs

Patients with gout frequently refuse or discontinue allopurinol because of fears about long-term medication use, concerns about the initial flare-triggering effect of ULT, or online misinformation about side effects. This is the primary reason gout remains poorly controlled in the majority of patients.

"A lot of people worry about taking a tablet every day for life, or have read things online about allopurinol. Can I tell you what the evidence actually says — including the bit about it sometimes causing a flare at the start, which is real but preventable?"

Address the allopurinol-flare concern explicitly and proactively — this is the single most important factor in improving adherence. Co-prescribe colchicine prophylaxis when starting ULT.

🏃 Physical Activity and Weight

Obesity significantly raises serum urate via increased purine synthesis. Weight loss reduces both serum urate and flare frequency. However, rapid weight loss (crash dieting, bariatric surgery) can paradoxically precipitate gout flares by mobilising urate from tissue stores. Exercise itself rarely triggers gout but dehydration during exercise does.

"Losing weight gradually would genuinely help reduce these attacks — but very rapid weight loss can actually trigger a flare temporarily, so we'd want to take a sustainable approach rather than a crash diet."

Recommend gradual weight loss (<1kg/week); physical activity should be encouraged but with adequate hydration; exercise referral scheme if available.

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases that score

"Tell me what's been happening — what's the pain been like and how did it start?"

"Have you had a fever or felt generally unwell with this — chills or shivering?" (septic arthritis exclusion)

"Are you on any water tablets — things like bendroflumethiazide? Any aspirin?"

"How many of these attacks have you had in the past year?" (ULT eligibility)

Deductions (examiner flags)

Not asking about systemic features (fever, rigors) — missing septic arthritis
Not reviewing medications for urate-raising drugs (diuretics, aspirin)
Not quantifying number of previous episodes (determines ULT eligibility)
Ignoring alcohol history as a modifiable trigger
Not asking about tophi or kidney stones (NICE NG219 ULT criteria)
Diagnosing gout without at least considering and excluding septic arthritis

🔴 Red — failing

No septic arthritis exclusion; no medication review; no ULT eligibility assessment; does not address alcohol; diagnoses gout based on history alone without examination plan; misses NICE NG219 criteria.

🟠 Amber — borderline

Septic arthritis risk mentioned but not explored; medications reviewed but thiazide-to-losartan switch not identified; previous episodes counted but ULT criteria not applied; alcohol noted but not quantified; tophi/kidney stones not asked.

🟢 Green — passing

Fever/systemic features asked explicitly; all urate-raising medications identified; previous episodes counted and ULT eligibility determined; alcohol quantified with AUDIT-C; tophi and kidney stones asked; ICE fully explored; diuretic switch to losartan identified if appropriate.

Step 2

Triage Engine — Emergency · Urgent · Routine

▲collapse

The vast majority of gout presentations are managed in primary care. The critical triage decision is whether the acute presentation might be septic arthritis — which cannot be excluded without joint aspiration. A patient with a hot swollen joint + fever + systemic illness = septic arthritis until joint aspiration proves otherwise. This is a same-day emergency regardless of prior gout history.

🔴 Emergency

Same-Day Hospital / Orthopaedics

Act immediately

Hot swollen joint + fever (>38°C) + systemically unwellSeptic arthritis until proven otherwise → same-day joint aspiration + orthopaedics / rheumatology
Immunosuppressed patient + acute hot joint (transplant, biologics, chemotherapy, steroids)Cannot clinically exclude septic arthritis → same-day aspiration regardless of prior gout history
Suspected sepsis with joint inflammation (HR >90, hypotension, confusion)Emergency 999 / A&E — IV antibiotics, joint aspiration, haemodynamic resuscitation
Rapidly spreading cellulitis with lymphangitisRisk of necrotising fasciitis → same-day A&E + IV antibiotics
Acute urate nephropathy (severe gout + acute kidney injury signs)Tumour lysis / massive hyperuricaemia → urgent renal assessment

🟠 Urgent

Same-Day / 2-Week Assessment

Urgent investigation

First episode of acute joint inflammation without prior diagnosisSerum urate, FBC, renal function, CRP same-day; arrange joint aspiration if diagnosis uncertain
Polyarticular acute gout — first presentationRheumatology referral within 2 weeks; consider reactive arthritis, RA, or pseudogout in DDx
Gout with AKI or rapidly worsening CKDUrgent renal function + urine dipstick; nephrology if AKI; allopurinol dose review
Severe tophaceous gout with ulceration or infection of tophusRisk of secondary infection; wound management + antibiotics if infected; rheumatology for complex ULT
Suspected haematological cause (very young, very high urate, cytopenias)FBC + haematology referral if lymphoma or polycythaemia suspected

🟢 Routine

Manage in Primary Care

GP practice

Acute gout flare — known diagnosis, afebrile, immunocompetentColchicine or NSAID for acute attack; serum urate after flare settles; review ULT eligibility
Recurrent gout — initiating ULTStart allopurinol 50–100mg OD with colchicine prophylaxis; 4-weekly titration; lifestyle review
Review of established allopurinol / monitoringSerum urate (target <360 µmol/L); renal function + FBC annually; dose adjustment if not at target
Medication review — thiazide for hypertensionSwitch to losartan ARB (mild uricosuric); review all urate-raising medications

🎓 SCA Checkpoint — Step 2TasksGlobal Skills

Triage phrases that score

"The most important thing I want to check is whether there is any chance this could be a joint infection rather than gout — they can look identical. I want to ask about whether you've had a fever or felt unwell."

"Because of the previous episodes and the way this has presented, I'm fairly confident this is gout — but I want to do a proper examination and some blood tests to be certain before we treat it."

"If you had a temperature or felt generally unwell with this, I would need to refer you to hospital today for a joint aspiration — that's the only way to be absolutely certain it's not an infection."

Triage deductions

Assuming gout without at least asking about fever and systemic illness
Not explaining to the patient why septic arthritis exclusion matters
Missing the immunosuppressed patient who requires same-day aspiration
Sending a febrile patient with a hot swollen joint home with colchicine alone

🔴 Red

Treats as gout without considering septic arthritis; no fever enquiry; no examination plan; gives medication without any diagnostic workup; misses immunosuppressed patient needing same-day aspiration.

🟠 Amber

Mentions septic arthritis but does not explain urgency; asks about fever but does not act on positive response; triage category correct but management plan inconsistent with urgency.

🟢 Green

Explicitly asks about fever and systemic illness; explains septic arthritis distinction to patient; correctly identifies immunosuppressed patients requiring same-day aspiration; appropriate triage with clear management plan; afebrile immunocompetent patient managed in primary care with investigations.

Step 3

Do I Need This Examination?

▲collapse

Physical examination in gout serves three purposes: confirming the clinical features of acute gout (erythema, warmth, swelling, exquisite tenderness), looking for tophi (ear cartilage, fingers, olecranon — pathognomonic of chronic tophaceous gout and a ULT criterion), and excluding septic arthritis — though the clinical distinction is impossible without aspiration in ambiguous cases. Also check for metabolic syndrome features (obesity, blood pressure, skin for psoriasis).

Examination	Why it matters	What finding changes management	Changes management?
Affected joint — erythema, swelling, warmth, tenderness, range of movement	Classic gout: exquisite tenderness, erythema extending beyond the joint, warmth, swelling. The degree of erythema and warmth is extreme — the joint is visibly red and hot to touch. Erythema extending as a diffuse ring beyond the joint margins is characteristic of gout; streaking lymphangitis suggests cellulitis or septic arthritis with soft tissue spread.Erythema confined to joint = gout likely; lymphangitis or erythema spreading rapidly up the limb = cellulitis / septic arthritis → A&E same day.	Rapidly spreading erythema → same-day A&E; lymphangitis → IV antibiotics; typical confined gout erythema → primary care management	YES — urgency decision
Temperature — axillary or oral	A temperature of >38°C in a patient with a hot swollen joint = treat as septic arthritis until joint aspiration is performed. Gout can cause low-grade fever (37.5–38°C), but significant fever should increase suspicion of septic arthritis. This is the single most important physical examination finding in gout triage.Temperature >38°C + hot swollen joint = same-day orthopaedic or rheumatology referral for joint aspiration, regardless of prior gout history.	Temp >38°C → same-day joint aspiration referral; temp <38°C with typical features in a well, low-risk patient → primary care management appropriate (fever may be absent in septic arthritis)	YES — critical triage decision
Tophi examination — ear cartilage, fingers, hands, elbows (olecranon), Achilles tendon	Tophi are firm, chalky-white deposits of urate crystals in soft tissue — pathognomonic of chronic tophaceous gout. They are most commonly found on the helix of the ear, over the joints of the hands and feet, the olecranon bursa, and the Achilles tendon. Their presence confirms the diagnosis and is a NICE NG219 absolute indication for ULT, with consideration of a lower target urate (below 300 µmol/L) to dissolve crystals.Tophi present → NICE NG219: offer ULT; consider a lower target below 300 µmol/L (rather than below 360 µmol/L).	Tophi confirmed → ULT indicated regardless of flare frequency; consider target <300 µmol/L; tophus ulceration → wound management + consider antibiotics	YES — ULT criteria and target
Blood pressure	Hypertension is strongly associated with gout and shares modifiable risk factors (obesity, alcohol, diet). If the patient is on a thiazide diuretic for hypertension, BP measurement confirms current control before any medication switch is considered. Uncontrolled hypertension may make a medication switch more complex.Well-controlled BP on thiazide → consider switch to losartan; poorly controlled BP → ensure BP control maintained during any switch.	BP well-controlled → proceed with losartan switch; BP uncontrolled → optimise BP before switching; hypertension + gout → dual-purpose losartan preferred	YES — medication switch decision
BMI and waist circumference	Obesity raises serum urate via increased purine synthesis and insulin resistance reducing renal urate excretion. BMI and waist circumference quantify obesity and provide a baseline for weight management advice. Intra-abdominal obesity (waist >102cm in men, >88cm in women) is a component of metabolic syndrome and an independent gout risk factor.Obesity + gout → weight management is a core intervention; gradual weight loss reduces serum urate and flare frequency.	BMI >30 → weight management plan; waist >102cm (men) / 88cm (women) → metabolic syndrome — comprehensive cardiovascular risk review	YES — lifestyle intervention
Skin examination — psoriasis plaques, nail pitting	Psoriatic arthritis can mimic gout and involves the same small joints (DIP joints, first MTP). Psoriasis itself is associated with hyperuricaemia. If psoriatic plaques or nail pitting are present, the diagnosis of "gout" may need to be reconsidered and rheumatology input sought. Missing psoriatic arthritis is a significant diagnostic error with therapeutic consequences.Psoriatic plaques + inflamed joints → reconsider diagnosis; rheumatology referral; psoriatic arthritis requires methotrexate / biologics, not just ULT.	Psoriatic plaques + inflammatory joint disease → rheumatology referral for confirmation; psoriatic arthritis diagnosis changes management entirely	YES — DDx and referral
Cardiovascular examination (if clinically indicated)	Gout is an independent cardiovascular risk factor — hyperuricaemia causes endothelial dysfunction and is associated with increased cardiovascular events. A heart examination is relevant in patients with heart failure (common comorbidity), arrhythmias, or in those in whom losartan substitution is being considered.Heart failure signs → loop diuretics cannot be stopped; continue managing gout alongside; heart failure + gout = complex management requiring specialist input if not controlled.	Signs of heart failure → loop diuretics cannot be changed; prioritise ULT initiation alongside diuretic; cardiology co-management if severe	Context — if cardiac comorbidity
Inspection of all other joints for sub-clinical involvement	In patients with established gout, particularly those with elevated serum urate and no ULT, tophi and sub-clinical crystal deposition may be present in multiple joints before they become acutely inflamed. Palpating other joints helps stage the disease and informs the urgency of ULT initiation.Multiple joints with tophi → severe tophaceous gout; consider rheumatology referral; consider target <300 µmol/L; ULT titration more aggressive.	Polyarticular tophi → consider lower ULT target (<300 µmol/L); consider rheumatology referral; more aggressive ULT titration needed	Context — in established gout

🎓 SCA Checkpoint — Step 3TasksRelating to OthersGlobal Skills

Examination communication that scores

"I'm going to take your temperature first — that's actually the most important thing I need to check before anything else, because if you have a fever with this joint, it changes what I need to do urgently."

"I'm also going to check your ears and the knuckles on your hands — I'm looking for small chalky deposits called tophi which would help me understand how long this has been building up."

"Your temperature is normal and you're otherwise well, with the same pattern as before — that's reassuring, although a normal temperature doesn't completely rule out infection. I'm happy to manage this here, with clear advice on when to come back."

Examination deductions

Not taking temperature — the most important examination finding in acute gout
Not checking for tophi — misses a NICE NG219 ULT criterion
Not examining blood pressure if thiazide is prescribed
Not communicating examination findings to patient

🔴 Red

No temperature check; no tophi examination; no BP if on antihypertensives; findings not communicated to patient; misses psoriasis in differential diagnosis.

🟠 Amber

Temperature taken but not communicated to patient therapeutically; tophi examination omitted; examination findings not used to guide clinical decision-making explicitly.

🟢 Green

Temperature taken and communicated first; tophi examined and findings shared; BP recorded if antihypertensive being considered for switch; normal findings communicated explicitly as reassurance about septic arthritis; BMI noted and weight management discussed.

Step 4

Do I Need This Investigation?

▲collapse

The definitive diagnosis of gout is by identification of monosodium urate (MSU) crystals in synovial fluid under polarised light microscopy — but this is rarely done in primary care. A clinical diagnosis is acceptable in a patient with typical podagra (first MTP joint attack with characteristic features) and an elevated serum urate. However: serum urate is often NORMAL or LOW during an acute flare (crystals mobilise from serum); investigation timing matters. If urate is below 360 µmol/L during a flare and suspicion remains, repeat it at least 2 weeks after the flare has settled (NICE NG219).

Investigation	Clinical question it answers	What result changes management?
Serum urate (repeat ≥2 weeks after flare settles if low)	Confirms hyperuricaemia; establishes baseline before ULT; guides ULT dose titration. CRITICAL: serum urate is often low or normal DURING an acute flare — crystals leave circulation during inflammation. Do not use a normal acute urate to exclude gout or dismiss the diagnosis. If below 360 µmol/L and suspicion remains, repeat at least 2 weeks after the flare has settled.	Baseline urate ≥360 µmol/L → confirms hyperuricaemia; guides allopurinol starting dose; monitor 4-weekly during titration until target reached (<360 µmol/L; consider <300 µmol/L if tophi, chronic gouty arthritis or ongoing frequent flares). Normal acute urate does not exclude gout.
Renal function + eGFR	CKD reduces urate excretion and is a cause of secondary hyperuricaemia; allopurinol requires dose adjustment in CKD to avoid toxicity; colchicine is contraindicated in severe CKD (eGFR <10); febuxostat may be preferred in allopurinol-intolerant patients with CKD. Must be checked before starting any ULT and at least annually on treatment.	eGFR <60 → adjust allopurinol dose (start lower; 50mg OD in CKD; titrate more slowly); eGFR <10 → colchicine contraindicated; eGFR <45 (CKD 3b–5) → consider rheumatology referral (NICE NG219); eGFR normal → standard dosing
FBC (full blood count)	Anaemia and raised white cell count in the context of gout may suggest haematological malignancy (lymphoma, polycythaemia vera) driving hyperuricaemia. Raised WCC is non-specific — occurs in both gout and septic arthritis. Baseline FBC before allopurinol is recommended as allopurinol rarely causes bone marrow suppression (SJS, aplastic anaemia).	Raised WCC → cannot distinguish gout from septic arthritis clinically; if fever present → joint aspiration; polycythaemia/anaemia/thrombocytosis → haematology referral; normal FBC → proceed with standard gout management
CRP / ESR (inflammatory markers)	Markedly elevated in acute gout (CRP commonly >100 mg/L during severe flare); also elevated in septic arthritis. Cannot distinguish between them. However, normal CRP during an apparently acute arthritis reduces the probability of active inflammation from either cause and may suggest mechanical or degenerative pathology rather than crystal or infective arthritis.	CRP >100 + acute joint → confirm diagnosis and treat; CRP mildly elevated + atypical features → reconsider DDx; normal CRP + acute joint pain → consider mechanical cause; very high CRP + fever → septic arthritis more likely → same-day aspiration
Synovial fluid analysis (joint aspiration — gold standard)	The definitive diagnosis. Monosodium urate crystals: needle-shaped, negatively birefringent under polarised light. Performed when: diagnosis is uncertain, first episode in atypical location, immunosuppressed patient, fever/systemic illness, single large joint (knee, ankle, wrist). In primary care: refer to emergency orthopaedics or rheumatology; GPs do not routinely perform joint aspiration.	MSU crystals + no bacteria → gout confirmed; bacteria on Gram stain / positive culture → septic arthritis → IV antibiotics + joint washout; CPPD crystals (rhomboidal, weakly positively birefringent) → pseudogout; no crystals + bacteria absent → send for culture; broaden DDx
Urine dipstick + urine microscopy	Haematuria may indicate uric acid nephrolithiasis (kidney stones) — an important comorbidity of gout and a NICE NG219 criterion for ULT. Proteinuria may indicate CKD contributing to hyperuricaemia. Urine dipstick is a simple first-line investigation in all patients with gout.	Haematuria → renal imaging (USS) to look for kidney stones; proteinuria → CKD workup; both present → urgent nephrology referral; normal dipstick → no immediate renal concern from gout
HbA1c / fasting glucose / lipids	Gout is part of the metabolic syndrome cluster. Type 2 diabetes, dyslipidaemia, and hypertension co-occur with gout at high rates. Comprehensive cardiovascular risk assessment (QRISK3) is indicated in patients with gout — each additional comorbidity raises the cardiovascular risk score that justifies statin therapy.	HbA1c ≥48 → T2DM diagnosis and management; lipids raised → statin consideration (QRISK3 ≥10%); comprehensive metabolic profile guides cardiovascular risk reduction alongside gout management
Plain X-ray of affected joint (if chronic tophaceous gout or diagnostic uncertainty)	X-ray is NOT required for diagnosis or management of a typical acute gout flare. However, in chronic tophaceous gout it can demonstrate the characteristic "punched-out" erosions with overhanging edges and preserved joint space — distinguishing from rheumatoid arthritis. Useful if the diagnosis is genuinely uncertain after assessment.	Punched-out erosions with overhanging edges + preserved joint space → chronic tophaceous gout confirmed; juxta-articular osteoporosis + joint space loss → rheumatoid arthritis; chondrocalcinosis → pseudogout (CPPD)

🎓 SCA Checkpoint — Step 4TasksGlobal Skills

Investigation communication that scores

"I'm going to take some bloods — including your kidney function, which is important because any medication I prescribe for gout needs to be adjusted based on how well your kidneys are working."

"I want to check your uric acid level — but I need to tell you something important: this test is more reliable at least 2 weeks after the attack settles, because the levels can look falsely normal during an attack. So I may need to repeat it."

"I'm also going to do a urine test to check for any sign of kidney involvement from the gout — sometimes it can affect the kidneys over time."

Investigation deductions

Diagnosing gout based on a "normal uric acid" during an acute flare — serum urate can be normal during acute inflammation
Not checking renal function before prescribing allopurinol
Not explaining to the patient why investigations are being requested
Using a normal serum urate to confidently exclude gout

🔴 Red

Prescribes allopurinol without checking renal function; uses acute normal serum urate to exclude gout; no urine dipstick; no inflammatory markers to support diagnosis; investigations not explained to patient.

🟠 Amber

Renal function checked but not linked to allopurinol dosing; serum urate checked during acute flare without caveat about timing; investigations ordered but rationale not explained; metabolic syndrome screening omitted.

🟢 Green

Renal function ordered pre-ULT; serum urate timing explained (4–6 weeks post-flare); urine dipstick for renal involvement; CRP/FBC to support diagnosis; metabolic syndrome screen (HbA1c, lipids) appropriate; rationale explained to patient.

Step 5

Reaching a Diagnosis & DDx — Explained in Plain Language

▲collapse

The diagnostic conversation in gout has three components: explaining the pathophysiology in accessible language (urate crystals, not just "too much rich food"), correcting common misconceptions that undermine treatment (gout is not self-inflicted and cannot be cured by diet alone), and — critically — introducing the concept of long-term urate lowering as disease management rather than just symptom suppression. The patient who understands the mechanism is significantly more likely to adhere to ULT.

🗣️ Explaining the Diagnosis in Plain Language — say something like this

"What is happening in your joint is this: a chemical in your blood called uric acid has built up to a higher level than your body can handle. When the level gets high enough, tiny sharp crystals — like microscopic needles — form in the joint fluid. Those crystals cause an intense inflammatory reaction in the joint — which is why the pain comes on so rapidly and is so extreme. It's those crystals that are causing the redness, the swelling, and the agony. The good news is that if we can bring your uric acid level down and keep it down, the crystals dissolve away over time and the attacks stop. The medication we use for this — allopurinol — has been used safely for over 60 years and is very effective."

💬 Addressing the patient's own explanation — why it may not be the full picture

"My wife says it's because I eat too much rich food — I just need to change my diet."
"Diet does play a role, and we'll definitely talk about some dietary changes that help. But I want to be honest with you: diet alone usually isn't enough to bring uric acid levels down to where they need to be. Most people with gout need medication alongside dietary changes. The good news is that the medication is straightforward, well-tolerated, and once your levels are stable, you should stop getting these attacks."

"My friend said allopurinol actually caused his gout to flare up — so I don't want to take it."
"Your friend is right that when you first start allopurinol, it can sometimes trigger a flare in the first few weeks — and I need to explain why, because it's important. When the allopurinol starts working and uric acid levels drop, crystals that are already in the joint can shift, and that movement can cause a temporary flare. It's actually a sign the treatment is working. We prevent this by prescribing a low-dose anti-inflammatory alongside the allopurinol for the first six months. Once you're established on it, it shouldn't happen."

A — Diagnosable in Primary Care

GP diagnoses and manages

Acute gout (podagra / articular) — Classic nocturnal onset, exquisite tenderness, erythema, swelling of first MTP joint. Elevated urate (4–6 weeks after flare). Responds to colchicine or NSAIDs within 24–48 hours.

Chronic tophaceous gout — Recurrent flares, tophi on examination, elevated serum urate, ULT criteria met. NICE NG219: consider target urate below 300 µmol/L.

Pseudogout (CPPD — calcium pyrophosphate deposition) — Often affects the knee; older patients; calcium deposits visible on X-ray. Managed similarly to gout acutely (NSAIDs, colchicine); no long-term ULT equivalent.

B — Suspected — Investigate and Refer

Rheumatology input needed

Psoriatic Arthritis

Inflammatory arthritis affecting similar joints to gout (DIP joints, first MTP); psoriasis or nail pitting present; may have elevated urate as comorbidity but requires methotrexate / biologics — not ULT alone.

Reactive Arthritis (Sexually Acquired)

Young adult, recent urethritis or GI infection, asymmetric oligoarthritis; Chlamydia or enteric organisms. STI screen, urethral swab, GI cultures. Managed with NSAIDs and treatment of underlying infection.

Early Rheumatoid Arthritis

Symmetrical small joint arthritis, morning stiffness, RF/anti-CCP positive; joint space loss on X-ray. Requires urgent rheumatology referral within 2 weeks for DMARDs.

C — Emergency — Act Now

Do not delay

Septic Arthritis

Hot swollen joint + fever + systemic illness → same-day joint aspiration. Staphylococcus aureus most common. IV antibiotics + joint washout. Permanent joint destruction if delayed >24h. Gout and septic arthritis can coexist.

Acute Urate Nephropathy (Tumour Lysis)

Massive hyperuricaemia from cell lysis (haematological malignancy treatment) → acute renal failure. Emergency IV fluids + rasburicase (uric acid oxidase) + urgent nephrology and oncology.

📊 Gout Classification — ACR/EULAR 2015 Criteria + NICE NG219 ULT Thresholds

Gout stage / category	Key features	ULT indicated?	Serum urate target
Acute gout — first episode	Podagra or single joint attack; no tophi; no renal stones; <2 flares/year	Discuss ULT with everyone; offer if CKD 3–5, diuretic therapy, tophi or chronic gouty arthritis (NICE NG219); consider if kidney stones	If ULT started: <360 µmol/L
Recurrent gout — multiple or troublesome flares	Repeated attacks; progressive joint damage likely without ULT; significant disability and pain burden	Yes — NICE NG219: offer ULT (allopurinol first-line)	<360 µmol/L
Gout with tophi	Tophi on examination (ear, fingers, olecranon); deposits of urate in soft tissue; may ulcerate	Yes — NICE NG219: ULT must be offered; tophi dissolve with sustained urate reduction	Consider <300 µmol/L (to dissolve tophi)
Gout + CKD or kidney stones	Renal involvement — nephrolithiasis or impaired renal function; urate nephropathy risk	Yes — NICE NG219: offer ULT in CKD stages 3–5; consider after a first flare if kidney stones	<360 µmol/L (adjust allopurinol for eGFR)
Septic arthritis — exclude immediately	Fever, systemic illness, hot swollen joint; fever not always present; immunosuppressed patients higher risk	ULT not relevant until septic arthritis excluded	N/A — emergency aspiration first

🎓 SCA Checkpoint — Step 5TasksRelating to OthersGlobal Skills

Diagnostic phrases that score

"What's happening is that tiny sharp crystals — like microscopic needles — have formed in your joint from a build-up of uric acid in your blood. Those crystals cause an intense inflammatory reaction, which is why the pain is so extreme."

"Diet does play a role, and we'll talk about that — but I want to be honest: for most people, diet alone isn't enough. The medication to lower uric acid is what actually stops the attacks long-term."

"About allopurinol and flares — your concern is valid. It can trigger a temporary flare at the start. We prevent this by prescribing a low-dose anti-inflammatory alongside it for the first six months. Once you're stable, it shouldn't happen."

Diagnostic deductions

Telling the patient that diet alone will cure gout — clinically inaccurate for most patients
Not explaining the crystal mechanism — patients who don't understand the mechanism won't adhere to ULT
Not addressing the allopurinol-flare concern proactively — this is the most common reason for ULT non-adherence
Not distinguishing gout from septic arthritis in the explanation

🔴 Red

No crystal mechanism explanation; tells patient diet will cure it; does not address allopurinol-flare concern; diagnoses gout without excluding septic arthritis; NICE NG219 ULT criteria not applied.

🟠 Amber

Gout diagnosis given but crystal mechanism not explained; ULT mentioned but rationale not given; allopurinol concern acknowledged but not fully explained; dietary advice given without caveating its limitations.

🟢 Green

Crystal mechanism explained in lay language; diagnosis distinguished from septic arthritis; diet limitation acknowledged honestly; allopurinol-flare mechanism explained with prophylaxis solution offered; NICE NG219 ULT criteria applied and matched to this patient; patient leaves understanding the condition.

Step 6

If Referral Is Needed — What the GP Does Before & During

▲collapse

Most gout is managed entirely in primary care. Referral is required when: the diagnosis is genuinely uncertain and requires aspiration; the patient has complex comorbidities that affect ULT choices (transplant, haematological malignancy); the patient has severe tophaceous gout requiring rheumatology input; or an acute presentation could be septic arthritis. The GP's pre-referral responsibilities include initiating acute pain management, ensuring the patient is not sent home without pain relief, and communicating the urgency clearly.

Condition / Scenario	Urgency	What GP does before referral	What GP must NOT do
Suspected septic arthritis (fever + hot joint + systemic illness)	Same-day — orthopaedics / rheumatology	Take temperature; take blood cultures (2 sets) before antibiotics if possible; insert IV access if systemically unwell; do not start oral antibiotics for a hot joint without aspiration results unless patient is septic and deteriorating. Communicate to hospital: joint affected, temperature, immune status, prior gout history.	Do NOT prescribe colchicine or NSAIDs and discharge a febrile patient with a hot joint — delay in treating septic arthritis causes permanent joint destruction. Do NOT start antibiotics without blood cultures if possible. Do NOT rely on prior gout history to exclude septic arthritis.
Immunosuppressed patient with hot joint (transplant, biologics, steroids, chemotherapy)	Same-day — joint aspiration required	Communicate immune status clearly to receiving team; provide medication list (including ciclosporin / azathioprine — critical for drug interaction planning if ULT is needed). Do not start allopurinol if patient is on azathioprine without specialist input — potentially fatal interaction.	Do NOT diagnose gout in an immunosuppressed patient based on history alone — aspiration is mandatory. Do NOT start allopurinol in a patient on azathioprine without specialist input.
Complex tophaceous gout / refractory gout not responding to allopurinol	Routine — rheumatology	Document: current allopurinol dose; maximum tolerated dose; serum urate on treatment; renal function; all previous ULT tried. Ensure patient is on adequate colchicine prophylaxis. Consider febuxostat (with cardiovascular caution) if allopurinol failed or not tolerated.	Do NOT refer with incomplete drug history or without documenting which ULT has been tried at what dose. Do NOT use febuxostat in patients with established CVD without discussing current MHRA cardiovascular advice with the patient.
Gout in organ transplant recipient (renal, cardiac, liver)	Routine — transplant team + rheumatology	Do not initiate ULT without transplant team review. Ciclosporin raises urate dramatically; azathioprine + allopurinol is a potentially fatal interaction (allopurinol inhibits xanthine oxidase → azathioprine accumulates → bone marrow suppression). Febuxostat is also a xanthine oxidase inhibitor and interacts with azathioprine — ULT choice needs specialist oversight.	Do NOT prescribe allopurinol to a patient on azathioprine. NEVER. The combination can cause fatal bone marrow suppression. If a patient transfers to your practice already on this combination, contact the prescribing specialist urgently before continuing.
Suspected haematological malignancy presenting with gout (young patient, very high urate, cytopenias)	Urgent — haematology suspected cancer pathway referral	FBC + blood film; LDH; urgent haematology referral if lymphoma or polycythaemia suspected. Document the very high urate, age, and haematological findings in the referral. Manage acute gout while awaiting haematology — treat the joint but do not delay referral for the underlying cause.	Do NOT attribute very high urate in a young patient solely to lifestyle — investigate for an underlying cause. Do NOT delay haematology referral while managing gout long-term.
Gout in pregnancy	Urgent — obstetrics + rheumatology	Gout in pregnancy is rare but occurs. NSAIDs should be avoided from 20 weeks unless clinically necessary (oligohydramnios, fetal renal dysfunction) and are contraindicated from 28 weeks (premature closure of the ductus arteriosus) — MHRA 2023. Colchicine is used cautiously in pregnancy with specialist input. Allopurinol and febuxostat: limited safety data; specialist decision required. Acute management: low-dose prednisolone is the safest option during pregnancy under specialist supervision.	Do NOT prescribe NSAIDs in pregnancy (avoid from 20 weeks, contraindicated from 28 weeks) or colchicine without specialist oversight. Do NOT start allopurinol in pregnancy without specialist review.

🎓 SCA Checkpoint — Step 6TasksRelating to Others

Referral phrases that score

"Because you have a temperature with this joint and I can't be 100% certain this isn't a joint infection, I need to send you to hospital today for a test — they will take a small sample of fluid from the joint which is the only way to be absolutely certain. I know that's not what you were expecting."

"I'm going to write to the rheumatology team because your gout has been difficult to control and I want to make sure you get the specialist input that will help manage this most effectively long-term."

Referral deductions

Not referring a febrile patient with a hot joint for joint aspiration
Starting allopurinol in a patient on azathioprine without specialist input
Not explaining to the patient why hospital referral is needed
Using febuxostat in a patient with established CVD without discussing the MHRA safety update

🔴 Red

Febrile patient with hot joint discharged with colchicine alone; allopurinol started in patient on azathioprine; no explanation given for hospital referral; febuxostat prescribed in CVD patient without cardiovascular caveat.

🟠 Amber

Referral made but reason not explained to patient; urgency correct but communication poor; allopurinol-azathioprine interaction not identified; transplant patient referred without transplant team coordination.

🟢 Green

Febrile patient appropriately referred same-day with clear explanation; allopurinol-azathioprine interaction identified and acted upon; referral reason explained empathetically; transplant team coordination mentioned; MHRA febuxostat caveat applied if relevant.

Step 7

Management — Expectation · Goals · Lifestyle · Prescribing · Drug Cards · Psychosocial · Follow-Up · Safety-Netting

▲collapse

Gout management has two distinct phases that the patient must understand: acute flare management (stop the current attack as quickly as possible with colchicine or NSAIDs) and long-term urate-lowering therapy (ULT with allopurinol to prevent future attacks by maintaining serum urate below the crystallisation threshold). These phases must NEVER be conflated — the biggest clinical error is stopping established allopurinol during an acute flare, which destabilises urate levels and provokes more attacks; new ULT is usually started 2–4 weeks after the flare settles (or during frequent flares with anti-inflammatory cover). NICE NG219 (2022) provides the current evidence base.

7A — Address the patient's expectation first: validate → explain → negotiate

🤝

Never dismiss the expectation — acknowledge it, share your reasoning, then agree a shared plan

Validate — name their expectation

The patient with an acute flare has one priority: stop this agonising pain today. The conversation about long-term ULT, diet, and lifestyle is entirely secondary to that need. Acknowledging the severity of the pain and the urgency of the relief request is both empathetic and therapeutically necessary — it creates the alliance needed for the longer discussion.

"I completely understand — this pain is severe, and dealing with it is absolutely the first priority. Let's start there and then I'll explain what we can do to stop this happening again."

Explain — share your clinical reasoning

The patient needs to understand why the acute treatment (colchicine) and the long-term treatment (allopurinol) are different things that serve different purposes. Without this explanation, they will conflate them, take the colchicine long-term, and refuse allopurinol as "too many tablets."

"The tablet I'm giving you now — colchicine — will calm the inflammation and stop this attack. Then, once it's settled, I want to talk about a different medication that actually lowers your uric acid level to prevent these attacks from happening at all."

Negotiate — offer something today

The acute attack requires immediate prescription. If ULT is indicated, plant the seed today and arrange a follow-up in 4–6 weeks once the flare has settled to initiate allopurinol. Usually wait until the flare has settled before starting allopurinol (NICE NG219 allows starting during frequent flares with anti-inflammatory cover) — explain why. Give the patient written information about gout to read while they recover.

"Today I'll prescribe you the colchicine to stop this attack. Once you're feeling better — usually about 4–6 weeks — I'd like to see you back to start you on the long-term medication. In the meantime, here's a leaflet that explains everything we've discussed today."

Key principle: Acute flare management and long-term ULT are two different conversations. Do not try to have both in full during the acute attack appointment — the patient is in too much pain to absorb the ULT discussion. Plant the seed, prescribe the acute treatment, book the follow-up, give written information.

7B — Why treatment matters: goals tailored to this patient

Treatment goals — shared with the patient

Stop the current attack within 24–48 hours Achieve serum urate <360 µmol/L on ULT (<300 if tophi) Zero flares per year once established on ULT at target Dissolve existing tophi over months to years with sustained target urate Prevent uric acid nephrolithiasis and protect renal function Review all urate-raising medications (switch thiazide to losartan if appropriate) Reduce cardiovascular risk alongside gout management Maintain serum urate at target with annual monitoring

Motivational language — tailored to the patient

"Most people who get their uric acid under control with allopurinol stop having attacks completely within 6–12 months. You won't need to avoid every food you enjoy for the rest of your life — the medication does the heavy lifting, and the lifestyle changes are a bonus on top."

"I know the idea of taking a tablet every day feels like a lot — but think about how many days a year you're currently unable to work or walk because of these attacks. The medication gives you those days back."

7C — Non-medication management: mechanism + evidence + tailored advice

Lifestyle advice supports general health but does not replace ULT — NICE NG219 found insufficient evidence that any specific diet prevents flares or lowers serum urate. Present lifestyle changes as a complement to medication, not an alternative. Framing: "These changes will make the medication work better and may reduce how much medication you need."

🍺

Alcohol Reduction

<14 units/week; avoid beer especially

Mechanism

Beer is doubly goutogenic: high purine content directly raises urate, and ethanol inhibits renal urate excretion. Even a single heavy drinking episode acutely raises serum urate significantly. Wine has a weaker effect on urate than beer or spirits. Alcohol also causes dehydration, further concentrating urate.

Practical

AUDIT-C at every gout consultation. Switch from beer to wine if alcohol is consumed. Avoid beer entirely during a flare or when starting ULT. Set a weekly unit limit and track it. Brief intervention using motivational interviewing. Drug and alcohol service if dependent.

Reducing excessive alcohol supports overall health; it does not replace ULT

🥩

Dietary Modification

Healthy, balanced diet; no restrictive gout diet

Mechanism

High-purine foods (red meat, organ meats, shellfish, anchovies, sardines) directly raise serum urate as purines are metabolised to uric acid. Low-fat dairy products (milk, yoghurt) are uricosuric — they increase renal urate excretion. Fructose-sweetened drinks (fruit juice, fizzy drinks) raise urate via hepatic fructose metabolism independently of purine content.

Practical

Advise a healthy, balanced diet and avoid sugar-sweetened drinks. Do not prescribe a restrictive gout diet — its effect is small next to ULT, and restrictive diets reduce adherence to what actually works.

Insufficient evidence that any specific diet lowers urate (NICE NG219)

💧

Hydration

Adequate hydration — no universal volume

Mechanism

Adequate hydration maintains renal urate excretion and prevents urate from concentrating in the distal tubule and joints. Dehydration — even mild — is a common precipitant of acute gout attacks, particularly during hot weather, exercise, or intercurrent illness. Uric acid is more soluble in dilute urine.

Practical

Encourage adequate hydration unless contraindicated, with individual advice in heart failure, CKD, frailty or fluid restriction. Increase intake during exercise, hot weather, or illness. Alkaline water or sodium bicarbonate supplementation can reduce uric acid stone formation (specialist indication). Avoid dehydrating beverages (alcohol, caffeine) as primary fluid source.

Adequate hydration reduces flare frequency and uric acid stone risk

⚖️

Weight Management

Gradual weight loss: <1kg/week target

Mechanism

Obesity increases serum urate via increased purine synthesis and insulin resistance reducing renal urate excretion. Each BMI unit reduction is associated with a meaningful reduction in serum urate. However, rapid weight loss paradoxically mobilises urate from tissue stores and can precipitate acute flares — gradual loss is essential.

Practical

Target gradual weight loss (0.5–1 kg/week) rather than crash dieting. Exercise should be encouraged but with adequate hydration. Exercise referral scheme if available. Bariatric surgery: associated with transient gout worsening post-operatively.

Gradual weight loss supports cardiometabolic health; crash diets provoke flares

💊

Medication Review

Switch thiazide → losartan ARB if clinically appropriate

Mechanism

Thiazide and loop diuretics are among the most common iatrogenic causes of gout in primary care. Losartan (ARB) has a mild uricosuric effect — it reduces serum urate by approximately 15–20% and provides equivalent antihypertensive efficacy to thiazides. Low-dose aspirin raises urate and cannot be stopped if cardiovascular indication exists.

Practical

For patients on bendroflumethiazide or indapamide for uncomplicated hypertension: review whether the thiazide is still needed and, if an alternative is suitable, discuss substitution — for example a calcium-channel blocker or losartan 50mg OD (titrate to 100mg if needed). Monitor BP and renal function (eGFR, K+) 1–2 weeks after switch and after each dose increase. Do not switch loop diuretics in heart failure patients. Low-dose aspirin: do not stop for gout.

Switching thiazide to losartan reduces serum urate by 15–20% and improves BP control

🍇

Specific Dietary Additions

Low-fat dairy, coffee, cherries, vitamin C

Mechanism

Low-fat dairy products are uricosuric via casein and lactalbumin effects on renal urate handling. Coffee (caffeinated) has been associated with lower urate levels in epidemiological studies — mechanism unclear. Cherries and cherry extract have modest anti-inflammatory and modest urate-lowering effects in small studies. Vitamin C supplementation has a small uricosuric effect.

Practical

2 portions low-fat milk or yoghurt daily. Coffee intake not restricted (unless cardiovascular concern). Cherry juice and vitamin C supplements: insufficient evidence — not routinely advised. These are supplements to medication, not replacements.

Optional adjuncts only — none replaces ULT

7D — Prescribing guide: acute management then ULT initiation

CRITICAL RULE: Do NOT stop established allopurinol during an acute flare. Stopping and restarting yo-yos the serum urate and provokes more attacks. Acute treatment: an NSAID, colchicine or a short course of oral corticosteroid, chosen by comorbidity and preference. ULT: start at least 2–4 weeks after the flare settles (or during frequent flares with effective anti-inflammatory cover), offering colchicine prophylaxis while the target is reached.

Acute Flare — First-Line Option: Colchicine

Colchicine 500mcg BD–TDS — start as early as possible in the attack (within 12 hours is optimal). Maximum 6mg per course. Start with lower frequency (BD or TDS) rather than the old high-loading dose regimen which caused significant GI toxicity.

NICE NG219: an NSAID, colchicine or a short course of oral corticosteroid for a flare, chosen by comorbidities and preference (colchicine often suits CKD and older people at adjusted doses)
Continue until flare fully resolves — usually 5–7 days
Dose reduction required in CKD (eGFR 10–50: max 500mcg BD; eGFR <10: avoid)
Drug interactions: statins (rhabdomyolysis risk), ciclosporin (toxicity risk), clarithromycin
Do NOT exceed maximum dose — colchicine toxicity is potentially fatal (multi-organ failure)

⚠ Colchicine is contraindicated in eGFR <10; toxic in overdose; drug interactions with statins and ciclosporin

Acute Flare — First-Line Option: NSAIDs

Naproxen 750mg, then 250mg every 8 hours (SPC) or Diclofenac 50mg TDS or Indomethacin 50mg TDS (most effective but most GI toxicity). Take at maximum dose immediately — do not start low. Add PPI gastroprotection (omeprazole 20mg OD) if >45 years or any GI risk factor.

Equal first-line option (NICE NG219) — suits younger patients with normal kidneys and no GI or CV risk
Avoid in CKD (acute tubular necrosis, fluid retention), heart failure, peptic ulcer disease, anticoagulants
Indomethacin most effective but highest GI toxicity — use naproxen as preferred NSAID in most patients
Duration: usually 5–7 days or until flare resolves

Add PPI gastroprotection; avoid in CKD, HF, anticoagulants; always use maximum anti-inflammatory dose acutely

Acute Flare — First-Line Option: Corticosteroids

Prednisolone 30–35mg OD for 3–5 days — an equal first-line option (NICE NG219), especially when colchicine and NSAIDs are unsuitable, or by preference. Particularly useful in: CKD (colchicine and NSAIDs both problematic), elderly patients, anticoagulated patients.

Intra-articular corticosteroid injection: highly effective for a single accessible joint (knee, ankle, wrist) — usually performed by GP with appropriate training or rheumatology
Oral prednisolone course: tapered over 5–7 days; check blood glucose in diabetics
Avoid repeated courses — adrenal suppression, osteoporosis, blood glucose dysregulation

First check blood glucose in diabetics; avoid repeated courses; exclude septic arthritis before any steroid injection

ULT — First-Line: Allopurinol (with Prophylaxis)

Start at least 2–4 weeks after the flare settles — or during frequent flares with effective anti-inflammatory cover
Starting dose: 50–100mg OD — start low; titrate upward every 4 weeks by 50–100mg
Target: serum urate <360 µmol/L (consider <300 µmol/L if tophi, chronic gouty arthritis or ongoing frequent flares)
Offer colchicine 500mcg OD prophylaxis while the target is reached (often up to 6 months, individualised) — prevents initiation flares
CKD: start 50mg OD; titrate more slowly; maximum dose depends on eGFR
HLA-B*5801 screening before allopurinol in Han Chinese, Thai, Korean ancestry — risk of Stevens-Johnson syndrome
NEVER combine with azathioprine — potentially fatal bone marrow suppression
Allopurinol is lifelong treatment — do not stop once urate at target (crystals will reform)

ULT — Alternative First-Line: Febuxostat (with Cardiovascular Caution)

First-line alternative by comorbidity and preference, or when allopurinol is not tolerated, contraindicated or ineffective (allopurinol first-line in major CVD)
Febuxostat 80mg OD (increase to 120mg OD if serum urate remains above target after 4 weeks)
Current MHRA advice: use febuxostat cautiously in pre-existing major cardiovascular disease (MI, stroke, unstable angina), particularly with a high tophus burden or when initiating ULT; NICE recommends allopurinol first-line in major CVD
Do NOT use febuxostat with azathioprine or mercaptopurine (same interaction as allopurinol)
Faster and more potent urate reduction than allopurinol — higher flare risk at initiation; colchicine prophylaxis essential for first 6 months
Offer colchicine prophylaxis while titrating, as with allopurinol

⚙ Interactive Medication Chooser — tick the patient profile, options re-tier live against NICE NG219 / SPC

A live, topic-scoped version of the standalone Medication Chooser. The static selector and reference cards below are unchanged.

7E — Medication options — guideline summary (no patient selection)

Situations this summary covers

Acute flare — needs immediate treatment now
CKD (eGFR <60) — dose adjustment required
Meets ULT criteria (multiple/troublesome flares, CKD 3–5, diuretics, tophi or chronic gouty arthritis)
Established cardiovascular disease (IHD, stroke, HF)
On azathioprine or mercaptopurine
On thiazide diuretic for uncomplicated hypertension
Tophi present on examination
Han Chinese, Thai, or Korean ancestry
Heart failure or on loop diuretic

What the guidance says

On azathioprine or mercaptopurine

⛔ CRITICAL: Allopurinol + azathioprine or mercaptopurine = POTENTIALLY FATAL. Allopurinol inhibits xanthine oxidase → azathioprine accumulates → bone marrow failure. Do NOT prescribe allopurinol. Febuxostat also interacts (xanthine oxidase inhibitor) — specialist transplant/haematology review before any ULT.

Acute flare — needs immediate treatment now

🔴 Acute Flare — Treatment Now

CKD (eGFR <60) — dose adjustment required:

CKD present → Colchicine 500mcg OD–BD (halved dose; avoid if eGFR <10)

CKD (eGFR <60) — dose adjustment required:

If colchicine contraindicated in severe CKD: Prednisolone 30–35mg OD × 3–5 days (safer in CKD than NSAIDs)

CKD (eGFR <60) — dose adjustment required:

⚠ Avoid NSAIDs in CKD — risk of acute tubular necrosis and fluid retention

Without CKD (eGFR <60) — dose adjustment required:

First-line options: Colchicine 500mcg BD–TDS (max 6mg per course); start within 12 hours of attack onset for best effect

Without CKD (eGFR <60) — dose adjustment required:

Or an NSAID: Naproxen 750mg then 250mg 8-hourly + PPI (omeprazole 20mg OD); or prednisolone 30–35mg OD × 3–5 days

Heart failure or on loop diuretic:

⚠ Heart failure present: avoid NSAIDs (fluid retention); use colchicine (adjusted for renal function) or prednisolone

Do NOT stop established allopurinol during a flare; start new ULT 2–4 weeks after it settles (sooner only with anti-inflammatory cover if flares are frequent)

Meets ULT criteria (multiple/troublesome flares, CKD 3–5, diuretics, tophi or chronic gouty arthritis) or Tophi present on examination

🟢 Long-Term ULT — Start After Flare Resolves

On azathioprine or mercaptopurine:

Allopurinol CONTRAINDICATED with azathioprine. Seek specialist review for febuxostat or alternative.

Han Chinese, Thai, or Korean ancestry:

⚠ HLA-B*5801 genetic screen required before allopurinol (Han Chinese, Thai, Korean ancestry — risk of Stevens-Johnson syndrome)

Han Chinese, Thai, or Korean ancestry:

If HLA-B*5801 negative: proceed with Allopurinol as normal. If positive: Febuxostat preferred (with CVD caveat if applicable)

CKD (eGFR <60) — dose adjustment required:

Allopurinol — start at 50mg OD (reduced starting dose in CKD); titrate more slowly (every 6–8 weeks); maximum dose depends on eGFR

None of the situations above:

Allopurinol 100mg OD — titrate by 50–100mg every 4 weeks until target serum urate reached

Serum urate target: If Tophi present on examination: <360 µmol/L; consider <300 µmol/L (to dissolve existing tophi)Otherwise: <360 µmol/L

Offer colchicine 500mcg OD prophylaxis while titrating to target (often up to 6 months) to prevent initiation flares

Established cardiovascular disease (IHD, stroke, HF) + without On azathioprine or mercaptopurine:

⚠ CVD present: Allopurinol is preferred over febuxostat — MHRA: use febuxostat cautiously in pre-existing major cardiovascular disease

On thiazide diuretic for uncomplicated hypertension

💊 Medication Switch

Heart failure or on loop diuretic:

Loop diuretic for heart failure — cannot switch; manage gout alongside diuretic therapy; offer ULT (diuretic therapy is a NICE NG219 criterion)

Without Heart failure or on loop diuretic:

Thiazide for uncomplicated hypertension → Switch to Losartan 50mg OD (ARB with mild uricosuric effect)

Without Heart failure or on loop diuretic:

Losartan reduces serum urate by ~15–20%; equivalent BP control; check eGFR + K+ at 1–2 weeks post-switch

Always check renal function before prescribing allopurinol · Review according to current SPC · Repeat serum urate ≥2 weeks post-flare if low during the flare

Guideline summary — each situation is shown with what the guidance says for it, as written. Nothing is selected or worked out for an individual patient. Check doses in the current SPC and local formulary.

7F — Drug reference cards: gout pharmacotherapy

Colchicine (Acute Flare)

Colchicine 500mcg tablets

✓ Recommended

First-line acute500mcg BD–TDS; max 6mg/course

✓ Prefer when

One of three first-line flare options (NICE NG219) — often suits older people and CKD at adjusted doses

Also used as ULT prophylaxis: 500mcg OD for first 6 months of allopurinol

Low-dose (500mcg BD–TDS) is as effective as old high-dose regimens with less GI toxicity

✗ Avoid if

eGFR <10 — contraindicated; accumulates to toxic levels in severe CKD

On ciclosporin — dramatic increase in colchicine toxicity; life-threatening

On statins — increased myopathy/rhabdomyolysis risk; use with caution; inform patient

eGFR 10–50 — halve the dose; maximum 500mcg BD; close monitoring

⚠ Side effects

Diarrhoea and nausea — most common; dose-related; commoner with old high-dose regimens

Myopathy (especially with statin co-prescription) — warn patient; stop if severe muscle pain

Colchicine toxicity (overdose): multi-organ failure, bone marrow suppression, circulatory failure — potentially fatal at relatively small doses

🔬 Monitor

Renal function (eGFR) before prescribing and at annual review

Maximum 6mg per acute course — prescribe appropriate quantity to prevent accidental toxicity

When used as prophylaxis (500mcg OD): continue for 6 months from start of ULT; review at 6 months

💬 Counselling

"Take one tablet two or three times a day during the attack and continue until the pain fully settles — usually about 5–7 days. If you get significant diarrhoea or vomiting, muscle pain or weakness, unusual tiredness, bruising or a sore throat, stop it and contact us urgently. Never take more than the amount prescribed. If you're also on a statin, tell me if you develop severe muscle aching."

Offering colchicine prophylaxis (500mcg OD) when initiating ULT is an SCA Task mark — failing to offer it is a clinical error. The allopurinol-initiation flare is predictable and preventable. Also: colchicine + ciclosporin is potentially fatal — always check immunosuppressant list before prescribing.

Naproxen (Acute Flare — NSAID)

Naproxen 500mg · Naprosyn · Generic

✓ Recommended

First-line acute (option)750mg then 250mg 8-hourly; + PPI

✓ Prefer when

Equal first-line option (NICE NG219) — younger patients with normal kidneys and no GI or CV risk

Preferred NSAID for gout — better GI tolerability than indomethacin

Start at maximum anti-inflammatory dose immediately — do not start low

✗ Avoid if

CKD (eGFR <30) — risk of acute tubular necrosis; avoid all NSAIDs in severe CKD

Heart failure — fluid retention worsening; avoid

Peptic ulcer disease — prescribe with PPI; avoid if active ulcer

Anticoagulants (warfarin, DOACs) — increased bleeding risk; use with extreme caution; colchicine or prednisolone preferred

⚠ Side effects

GI upset, peptic ulceration — prescribe PPI (omeprazole 20mg OD) in patients >45 years

Fluid retention, oedema — relevant in hypertension, HF, CKD

Renal impairment with prolonged use — monitor eGFR

🔬 Monitor

Renal function (eGFR) if used repeatedly; BP in hypertensive patients

Prescribe PPI alongside in patients >45 years or with any GI risk factor

💬 Counselling

"Take this at the full dose immediately — this is one situation where you do need the highest dose to dampen the inflammation quickly. Take it with food to protect your stomach. I'm also prescribing a stomach-protecting tablet to take alongside it. Continue until the pain fully settles — usually about a week — then stop."

NICE NG219 (2022): consider adding a PPI for people taking an NSAID for a gout flare — omitting gastroprotection in an older patient or one with GI risk factors is an SCA prescribing error. Always state PPI explicitly when prescribing NSAIDs for gout in the SCA consultation.

Prednisolone (Acute Flare — First-Line Option)

Prednisolone 5mg / 30mg tablets · Oral corticosteroid

✓ Recommended

First-line acute (option)30–35mg OD × 3–5 days

✓ Prefer when

Colchicine or NSAIDs unsuitable, or by patient preference — an equal first-line option (NICE NG219)

Severe CKD — colchicine and NSAIDs both problematic; prednisolone safer

Elderly patients on anticoagulants where NSAID risk is unacceptable

Intra-articular corticosteroid injection: highly effective for single accessible joint

✗ Avoid if

Septic arthritis not excluded — corticosteroids will worsen joint infection

Uncontrolled diabetes — acute hyperglycaemia; check and monitor blood glucose

Active infection — any systemic infection is a caution; corticosteroids impair immune response

⚠ Side effects

Blood glucose elevation — especially in diabetes; warn patient to monitor more frequently

Mood change, sleep disturbance, fluid retention

With repeated courses: adrenal suppression, osteoporosis, cataracts — avoid frequent short courses

🔬 Monitor

Blood glucose in diabetics — check before and during course

BP in hypertensive patients — fluid retention can worsen BP

Duration: 3–5 days at 30–35mg OD; taper not needed for short courses

💬 Counselling

"I'm prescribing a short course of steroid tablets to calm this attack because the other options aren't suitable for you. Take them once a day in the morning for 5 days. If you have diabetes, please check your blood sugars more frequently — steroids can temporarily raise them. Don't stop early even if you feel better."

The critical SCA point with prednisolone in gout: septic arthritis must be excluded before prescribing corticosteroids. Corticosteroids in a septic joint will suppress inflammation, mask deterioration, and lead to catastrophic joint destruction. This sequence (septic arthritis exclusion → then prednisolone) must be demonstrated in the SCA to score on the Tasks domain.

Allopurinol (ULT — First-Line)

Allopurinol 100mg / 300mg tablets · Zyloric · Generic

✓ Recommended

First-line ULTStart 50–100mg OD → titrate to target

✓ Prefer when

All patients meeting ULT criteria (NICE NG219) — first-line choice

Preferred over febuxostat in patients with established CVD (safer cardiovascular profile)

CKD — adjust dose by eGFR; still preferred over febuxostat in most CKD patients

✗ Avoid if

Azathioprine or mercaptopurine co-prescription — potentially FATAL; inhibition of xanthine oxidase → azathioprine toxicity → bone marrow failure

Allopurinol hypersensitivity syndrome (rare but severe: SJS, TEN, DRESS) — screen Han Chinese/Thai/Korean with HLA-B*5801 before starting

Acute gout flare — usually start 2–4 weeks after it settles (during frequent flares only with anti-inflammatory cover); never stop established allopurinol

⚠ Side effects

Initiation flare — crystals mobilise as urate drops; prevent with 6-month colchicine prophylaxis

Skin rash (1–5%) — any rash: stop and seek same-day assessment (DRESS/SJS risk); rechallenge only on specialist advice; severe rash (SJS/TEN) rare but life-threatening → stop permanently, emergency referral

GI upset — take with food; switch formulation if problematic

🔬 Monitor

Serum urate: 4 weeks after each dose increase; at target → annual monitoring

Renal function (eGFR) and FBC: baseline, at 3 months, then annually

Titration: 50–100mg increases every 4 weeks until serum urate at target (<360 or <300 µmol/L)

💬 Counselling

"I'm going to start you on allopurinol — but not during this current attack. We'll wait until you're fully better. When we start it, we also prescribe a low-dose anti-inflammatory tablet alongside it for 6 months, because the allopurinol can temporarily trigger a flare at the start. Once your uric acid level is stable and at the target, that risk disappears. This medication is lifelong — if you stop it, the crystals will build up again and the attacks will return. You should not stop it without speaking to me first."

Three mandatory SCA allopurinol points: (1) Usually start once the flare has settled, and never stop established ULT during a flare; (2) Offer colchicine prophylaxis while titrating to target (often up to 6 months); (3) HLA-B*5801 screening before allopurinol in Han Chinese, Thai, or Korean patients. Failure to mention all three is a clinical error. The allopurinol-azathioprine interaction is potentially fatal — always check the drug list before prescribing.

Febuxostat (ULT — Alternative First-Line)

Adenuric 80mg / 120mg tablets

✓ Recommended

Alternative ULT80mg OD → 120mg if needed

✓ Prefer when

First-line alternative by comorbidity and preference, or allopurinol not tolerated, contraindicated or ineffective

Transplant patients not on azathioprine — only on transplant/rheumatology advice (febuxostat is a xanthine oxidase inhibitor)

More potent urate reduction than allopurinol — useful in severe tophaceous gout

✗ Avoid if

Pre-existing major cardiovascular disease (MI, stroke, unstable angina) — current MHRA advice: use cautiously, particularly with a high tophus burden or when initiating ULT; allopurinol first-line (NICE); discuss risk-benefit explicitly with patient

Azathioprine or mercaptopurine — same interaction mechanism as allopurinol; DO NOT combine

Theophylline — febuxostat inhibits xanthine oxidase → theophylline levels rise; monitor

⚠ Side effects

Initiation flare — more common and more severe than with allopurinol; 6-month colchicine prophylaxis essential

Liver function abnormalities — LFTs at baseline and 3 months

Cardiovascular events — current MHRA advice; discuss with patients who have major cardiovascular disease before prescribing

🔬 Monitor

Serum urate: 4 weeks after start; at target → annual monitoring

LFTs: baseline + 3 months

Cardiovascular events: annual review; reassess risk-benefit in patients developing CVD

💬 Counselling

"This medication works in a similar way to allopurinol but is used when allopurinol is not suitable. I need to mention that there was a study showing it might carry a slightly higher risk of heart problems compared to allopurinol — so I'll monitor you carefully while you're on it. Like allopurinol, it can cause a temporary flare when you first start it, so we'll prescribe the anti-inflammatory tablet alongside it for the first six months. And again — this is a lifelong medication."

Current MHRA febuxostat advice (use cautiously in major cardiovascular disease) is a mandatory SCA prescribing point. If you prescribe febuxostat without discussing cardiovascular risk with the patient, and the patient has established CVD, this is a clinical governance and SCA Tasks deduction. NICE recommends allopurinol first-line in major cardiovascular disease.

Losartan ARB (Thiazide Switch + Uricosuric)

Losartan 50mg / 100mg · Cozaar · Generic ARB

✓ Recommended

Antihypertensive switch50mg OD → 100mg

✓ Prefer when

Patient with gout on thiazide diuretic for uncomplicated hypertension — switch to losartan

Losartan is an ARB with a mild uricosuric effect (lowers serum urate by 15–20%)

Provides equivalent or superior BP control to bendroflumethiazide with the added uricosuric benefit

CKD: ARBs are renoprotective — particularly beneficial in gout + CKD + hypertension

✗ Avoid if

Pregnancy — teratogenic; causes foetal renal dysgenesis

Bilateral renal artery stenosis

Hyperkalaemia (K+ >5.5 mmol/L) — ARBs raise potassium; monitor carefully in CKD

⚠ Side effects

Hypotension — particularly at initiation; check standing BP in elderly patients

Hyperkalaemia — especially in CKD; check U&E/K+ 1–2 weeks after starting and after each dose increase

No cough (unlike ACEi) — this is an advantage of ARB over ACEi for gout patients

🔬 Monitor

BP, eGFR, and electrolytes (K+) 1–2 weeks after switching to losartan and after each dose increase

Serum urate after switch — expect 15–20% reduction; may reduce dose of allopurinol needed

💬 Counselling

"I'm suggesting we switch your blood pressure tablet from the water tablet to a different type called losartan. This controls blood pressure in a very similar way, but it also has the added benefit of slightly lowering your uric acid — so it's a double benefit for your gout. I'll check your kidney function and potassium levels 1 to 2 weeks after we switch to make sure everything is settled."

The thiazide-to-losartan switch is a high-yield SCA prescribing task — it demonstrates medication review, knowledge of iatrogenic gout, and NICE NG219 awareness in a single action. Identifying that bendroflumethiazide is the antihypertensive and proposing losartan as a gout-beneficial alternative is a strong Tasks domain score. Always check eGFR and K+ before and after switching.

7G — Psychosocial impact of the diagnosis: work, relationships, identity & daily life

🤝

Living with gout — the stigma, the disability, and the need for lifelong management

Gout is one of the most disabling acute conditions in primary care — the pain is rated by patients as equivalent to childbirth. Yet it carries profound stigma as a "disease of excess" that is self-inflicted. This combination of extreme pain and shame creates a significant psychosocial burden that is rarely addressed in consultations. The GP who takes time to destigmatise the condition, address the occupational and relationship impacts, and frame ULT as a route to a normal life will dramatically improve long-term outcomes.

😤

Stigma and Shame

Gout is culturally portrayed as a disease of gluttons and drinkers — "a rich man's disease." Many patients internalise this narrative, feel deep shame, and blame themselves entirely. This delays presentation, reduces medication adherence, and prevents open discussion.

Explicitly challenge the narrative: gout has strong genetic determinants, and many patients develop it with minimal dietary excess. Normalising the condition as metabolic rather than moral changes the consultation dynamic entirely.

Provide evidence: identical dietary intake produces very different serum urate levels in different individuals due to genetic variation in urate transporters.

"I want to be clear: gout is a metabolic condition with a strong genetic component. It is not simply caused by excess. Many people who develop gout eat no differently from people who don't."

💼

Occupational Disability

Acute gout attacks are severely disabling — patients in manual occupations (construction, agriculture, driving, healthcare) may be completely unable to work for days or weeks during a flare. Self-employed patients face financial consequences directly.

For patients with recurrent flares, gout represents a significant loss of earnings and productivity. Framing ULT as "preventing future attacks that stop you working" is a powerful motivational tool for occupationally active patients.

A fit note is appropriate for severe acute gout preventing work. For those with chronic tophaceous gout, disability assessment may be needed.

"How much is this affecting your ability to work? I can provide a fit note for this episode — and the long-term medication should stop these attacks happening at all in the future."

🏡

Impact on Family and Relationships

Gout attacks are so painful that they affect sleep for the entire household. Partners often become carers during attacks. Recurrent episodes strain relationships — the partner who "told him to cut down on beer years ago" may experience frustration as well as concern.

Alcohol reduction advice needs to be framed sensitively — for many patients, drinking is a social and relationship activity, and cutting down requires family support.

If lifestyle changes are being recommended, involving the partner or family member (with patient consent) in the consultation can significantly improve adherence to dietary and alcohol advice.

"These attacks clearly affect your whole household, not just you. If it would be helpful, we could involve your partner in the conversation about the lifestyle changes — having support at home makes a big difference."

📋

Long-Term Medication Acceptance

The idea of taking a daily medication for life is a significant psychological barrier for many patients. This is amplified by the fact that gout attacks come and go — patients feel "well" between attacks and question the need for daily medication when they are asymptomatic.

The key educational message: allopurinol treats the underlying metabolic condition, not the symptoms. The crystal burden in joints and soft tissues continues to build silently between attacks — the attacks are just the visible manifestation of an ongoing process.

Use the analogy of blood pressure treatment: "We treat high blood pressure every day even when you feel fine — because the damage is building up silently. Allopurinol works the same way."

"I understand that taking a daily tablet when you feel fine between attacks seems strange. But the crystals are building up in your joints every day — the attacks are just when they cause enough inflammation to notice. The medication prevents that silent build-up."

🧪

Understanding of the Condition

Gout has one of the lowest health literacy levels of any common chronic condition. The majority of patients believe: gout is caused entirely by diet; diet change alone will cure it; allopurinol is not needed if they eat well; they can stop allopurinol once they feel better; gout is not a serious disease.

All of these beliefs are inaccurate and will prevent effective management. The educational consultation — explaining the crystal mechanism, the role of genetics, and the rationale for lifelong ULT — is as important as the prescription itself.

Written information (NHS gout leaflet, Arthritis UK) should be provided at every consultation involving ULT initiation.

"I'm going to give you a leaflet about gout that explains everything we've discussed. I'd really like you to read it before your next appointment — it addresses a lot of the questions people have about the medication."

💪

Self-Efficacy and Empowerment

Patients who understand the mechanism of their condition and have a clear, achievable treatment plan report significantly better outcomes than those who are simply given a prescription. Shared decision-making in gout — explaining the target serum urate, showing the patient their results, and demonstrating the downward trend — creates engagement and adherence.

Some patients respond well to the "treat-to-target" framing: "Once your uric acid number is below 360, we should stop having these attacks. Let's work together to get to that number."

Patient ownership of the monitoring (understanding what the urate result means) is associated with better long-term adherence than passive medication receipt.

"I'm going to show you your uric acid number today, and tell you where we need to get it to. Once we hit that target, the attacks should stop. Let's work towards that together."

7H — Follow-up schedule

1–2 weeks — Acute flare review

Review response to colchicine or NSAID. Has the flare resolved? If not fully resolved: consider whether diagnosis is correct — persistent single hot joint despite treatment raises concern for septic arthritis or reactive arthritis. Assess any side effects from acute treatment. Reinforce that allopurinol will be initiated once fully resolved.

Flare resolution checkSeptic arthritis if persistentPlant ULT seed

4–6 weeks — ULT initiation + blood results

Serum urate (repeat now if it was below 360 during the flare). Renal function, eGFR, FBC before starting allopurinol. HbA1c and lipids if not recently done. Initiate allopurinol 50–100mg OD with colchicine 500mcg OD prophylaxis. Implement thiazide-to-losartan switch if appropriate. Full ULT counselling. Lifestyle review.

Serum urate baselineAllopurinol initiationColchicine prophylaxis

4–8 weeks after ULT start — Serum urate + dose titration

Serum urate on treatment. If above target (<360 µmol/L): increase allopurinol by 50–100mg. Review tolerability (rash, GI upset). Any flares since starting? (Expected — reassure; do not stop allopurinol; colchicine prophylaxis should be preventing them.) Continue colchicine prophylaxis.

Urate on treatmentDose titrationTolerability check

6 months — Colchicine prophylaxis review + urate at target?

Is serum urate at target (<360 µmol/L or <300 µmol/L if tophi)? If yes and flare-free, consider stopping colchicine prophylaxis (duration individualised — often up to 6 months; continue longer for ongoing flares or tophi). If not at target: dose increase needed. Review alcohol, diet, and hydration. Renal function and FBC check. Review for tophi regression (if present at baseline).

Stop colchicine prophylaxis at 6 monthsUrate at target?

Annual review — Monitoring + CVD risk

Annual serum urate (target <360 µmol/L). Annual renal function + FBC + eGFR. Annual alcohol and lifestyle review. Annual cardiovascular risk assessment (QRISK3 — gout is an independent CVD risk factor). If tophi present: assess for regression. If flares have recurred: reconsider ULT adherence and dose adequacy.

Annual urate + renal function + FBCCVD risk assessmentLifestyle and adherence

7I — Monitoring: the URATES mnemonic + treatment targets

Memory rule — Gout Monitoring: URATES

Urate serum level (repeat ≥2 weeks post-flare if low; target <360 µmol/L, consider <300 with tophi, chronic gouty arthritis or ongoing flares; 4-weekly during titration) · Renal function (eGFR + electrolytes — allopurinol dose must match eGFR; annual monitoring) · Alcohol (AUDIT-C at every consultation; beer most goutogenic) · Tophi (examine at every review — regression confirms ULT working) · Escalation (if urate above target at 12 weeks at maximum tolerated allopurinol dose → consider febuxostat with CVD caveat or rheumatology referral) · Statin/azathioprine interactions (check drug list at every allopurinol prescription)

Drug / Intervention	Monitoring parameter	Timing	Action threshold
Allopurinol	Serum urate; eGFR; FBC; skin (rash)	4 weeks after each dose change; 3 months; then annually	Serum urate above target → increase dose by 50–100mg; skin rash → stop and refer; eGFR deterioration → dose reduction
Colchicine (acute)	Symptom resolution; GI tolerability; renal function	1–2 weeks post-prescription review	Not resolving in 5–7 days → reconsider diagnosis; significant diarrhoea, vomiting or muscle pain → stop and seek urgent advice; eGFR <10 → contraindicated
Colchicine (prophylaxis)	Flare frequency; tolerability; duration of prophylaxis	6 months — stop at 6 months if urate at target and flare-free for 3 months	Flares despite prophylaxis → review ULT dose adequacy; continued flares after 6 months → ULT dose not yet at target
Febuxostat	Serum urate; LFTs; cardiovascular events; adherence	4 weeks after start; LFTs at 3 months; annual review	LFT abnormality >3× ULN → stop; cardiovascular event → reassess risk-benefit vs allopurinol switch
Losartan switch (from thiazide)	BP; eGFR; serum potassium; serum urate	1–2 weeks after switch (and after dose increases); then 6-monthly	K+ >5.5 → dose reduction or renal review; BP not controlled → titrate to 100mg; serum urate → expect 15–20% reduction

Patient group	Serum urate target	Allopurinol starting dose
Standard (no tophi, <2 flares/year on ULT)	<360 µmol/L	100mg OD; titrate every 4 weeks
Tophi, chronic gouty arthritis or ongoing flares despite <360	Consider <300 µmol/L	100mg OD; titrate more aggressively
CKD stage 3 (eGFR 30–60)	<360 µmol/L	50mg OD; titrate slowly (every 6–8 weeks); consider rheumatology referral if eGFR <45 (CKD 3b)
CKD stage 4–5 (eGFR <30)	<360 µmol/L — specialist input	50mg OD or less; rheumatology input required
Frail or high-risk (not age alone)	<360 µmol/L	Start below 100mg OD; titrate slowly; monitor eGFR closely
Han Chinese / Thai / Korean ancestry	<360 µmol/L	HLA-B*5801 screen before starting; if positive → do not use allopurinol; consider febuxostat

7J — Safety-netting: exact phrases + medico-legal rationale

⚠ Three scenario-specific phrases — use these verbatim

Why safety-netting matters beyond clinical care

Septic arthritis missed as gout is one of the most common causes of orthopaedic clinical negligence — documented safety-net is essential medico-legal protection

Allopurinol hypersensitivity syndrome (SJS/TEN) — failure to warn about rash and instruct to stop immediately is a prescribing safety failure

Allopurinol + azathioprine interaction — failure to screen for this combination before prescribing can cause fatal bone marrow suppression

Febuxostat cardiovascular risk — current MHRA advice (use cautiously in major CVD) means documenting a risk-benefit discussion before prescribing in patients with CVD

GMC Good Medical Practice: patients must be given information to recognise deterioration and know when to return urgently

Colchicine toxicity: prescribing larger quantities than necessary creates overdose risk; document quantity prescribed and rationale

1–2 weeks: Flare resolution check; if persistent → reconsider diagnosis; septic arthritis if fever develops

4–6 weeks: Serum urate (post-flare baseline); renal function; initiate allopurinol with colchicine prophylaxis

Same day / A&E: Fever + hot joint; rash on allopurinol; lymphangitis; signs of systemic sepsis

🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills

Closing the consultation

"Today I'm giving you colchicine to stop this current attack. I'll see you in 4–6 weeks to check bloods and get you started on the long-term treatment — we'll not start that today while you're still in a flare."

"If at any point you develop a fever or feel systemically unwell with a joint attack, go to A&E — don't wait for an appointment here."

"If you develop any rash while on the allopurinol — once we start it — stop it immediately and contact us the same day."

"I also want to suggest switching your blood pressure tablet from the water tablet to a different type — losartan — which actually has a small benefit for gout on top of controlling your blood pressure."

"Is there anything else on your mind before we finish?"

Deductions — closing

Starting allopurinol during an infrequent acute flare — NICE NG219 advises waiting 2–4 weeks after it settles
Not offering colchicine prophylaxis when starting allopurinol
Not giving the septic arthritis fever safety-net
Not giving the allopurinol rash safety-net
Prescribing allopurinol without checking renal function (eGFR) first
Not identifying the thiazide diuretic as a modifiable gout risk factor

Tasks domain — full criteria

Septic arthritis excluded clinically (temperature, systemic features) before treating as gout
Acute treatment prescribed correctly: colchicine 500mcg BD–TDS or NSAID + PPI
ULT eligibility determined (multiple or troublesome flares, CKD 3–5, diuretics, tophi, chronic gouty arthritis) per NICE NG219
Allopurinol NOT started during flare; 4–6 week follow-up arranged for ULT initiation with colchicine prophylaxis
Thiazide-to-losartan switch identified if applicable; renal function before allopurinol

Relating to Others — full criteria

ICE explored — patient's beliefs about diet causing gout, allopurinol-flare concern, expectations about treatment
Crystal mechanism explained in plain language ("microscopic needles in the joint")
Diet limitation acknowledged: "diet alone is usually not enough"
Allopurinol-initiation flare mechanism explained with prophylaxis solution
Stigma addressed: "gout is not just a disease of excess — there is a strong genetic component"
Closing question asked: "Is there anything else on your mind?"

🔴 Red — failing

Starts allopurinol during flare; no septic arthritis consideration; no colchicine prophylaxis; no medication review (misses thiazide); no ULT eligibility assessment; no safety-nets for fever/rash; prescribes without checking renal function.

🟠 Amber — borderline

Correct acute treatment but ULT timing wrong; colchicine prophylaxis not mentioned; thiazide identified but switch not offered; allopurinol-flare concern not addressed; fever safety-net vague or absent; renal function not mentioned pre-ULT.

🟢 Green — passing

Septic arthritis excluded; correct acute treatment prescribed; allopurinol deferred until post-flare with colchicine prophylaxis planned; thiazide-to-losartan switch offered; fever and rash safety-nets given; renal function before ULT; crystal mechanism explained; allopurinol-flare concern addressed proactively.

"I woke up in the middle of the night with the most horrendous pain in my big toe — I couldn't even bear the bedsheet touching it. My wife thinks it's gout. Is it? I'm hoping you can give me something to sort it."

Who you are

Mr Rajiv Patel, 54 years old, self-employed plumber. Woke at 3 am with severe pain, redness, and swelling of the right big toe — worst pain of his life; cannot bear the bedsheet touching it. Two similar episodes in the past 18 months, both self-limiting within a week, attributed to "overdoing it at the pub." Takes bendroflumethiazide 2.5mg OD for hypertension (prescribed 3 years ago) and atorvastatin 20mg OD. Drinks approximately 18–20 units of alcohol per week, predominantly beer. Eats red meat 4–5 times per week. Rarely drinks water during the working day. BMI 31. No known kidney disease. No tophi visible but examining ears and hands during examination is expected. BP on examination: 138/84 mmHg.

Hidden agenda

Rajiv is worried the word "gout" means something is seriously wrong with his blood — possibly kidney disease or even cancer. His real fear is also that he will have to stop drinking entirely and change his diet completely, which would affect his social life (pub darts team). He is anxious about taking "yet another tablet" — already on two medications. He will not disclose these concerns unless directly asked. If offered allopurinol, he will express concern that a friend "had a terrible flare when he started allopurinol and came straight off it" — he needs the initiation flare mechanism fully explained before he will accept the prescription. He will also quietly wonder whether the colchicine is safe with his statin — a useful teaching point if the doctor raises it proactively.

Symptoms if asked directly

Pain: right first MTP joint; 9/10; cannot weight-bear; extreme allodynia (bedsheet)
Onset: 3 am, woke from sleep, reached maximum intensity within 4 hours
Previous episodes: 2 in past 18 months (both self-limiting; both attributed to alcohol)
Systemic: NO fever; not generally unwell; no rigors — temperature will be 37.2°C on examination
No tophi visible (though ears and hands should be examined — negative in this scenario)
Alcohol: 18–20 units/week, predominantly beer; large drinking session 2 nights before this episode
Diet: red meat 4–5 times/week; shellfish occasionally; cola and fruit juice daily
Hydration: minimal water intake during working day — this connection is new to him
Medications: bendroflumethiazide 2.5mg OD (hypertension); atorvastatin 20mg OD
No azathioprine, ciclosporin, or immunosuppressants
No kidney stones; no haematuria; no known CKD

Lifestyle + bonus details

Self-employed plumber — cannot work during severe attacks; financial impact is direct and significant
Drinks beer with workmates after jobs — socially embedded; will resist complete alcohol cessation but is open to reduction if framed practically
Wife has told him to cut down on beer for years; supportive but frustrated with repeated episodes
Bonus detail (if doctor asks about caffeine/fizzy drinks): admits to daily cola and fruit juice — has never connected fructose drinks to gout
Bonus detail (if hydration raised): he barely drinks water during long working days — genuinely receptive when the dehydration-gout link is explained
Bonus detail (if colchicine + statin interaction raised): will ask if it is safe — an opportunity for the doctor to counsel on the muscle pain monitoring point

"My mate said allopurinol made his gout ten times worse — he came straight off it after a week. Are you absolutely sure that's the right thing for me? And do I really have to stop drinking completely? That would basically end my social life."

Resolution: Rajiv will accept the plan if the doctor: (1) explicitly checks temperature and rules out septic arthritis — explains why this matters; (2) gives colchicine today with clear dosing instructions; (3) acknowledges the severity of the pain empathetically; (4) explains the crystal mechanism ("microscopic needles"); (5) addresses his hidden fear about kidney disease — explains what the blood tests will check; (6) proactively explains the allopurinol-initiation flare mechanism and the colchicine prophylaxis solution before he raises it; (7) clarifies that complete alcohol cessation is not required — reducing beer specifically is the key target; (8) identifies bendroflumethiazide as a modifiable risk and offers the losartan switch; (9) gives the fever safety-net explicitly; (10) confirms allopurinol will NOT start today — follow-up in 4–6 weeks once fully better.

🏥

Clinic Quick Reference

Gout — Clinical Decision Framework

NICE NG219 (2022) · ACR/EULAR 2015 Criteria

▼expand

🚦 1 — Triage System

Patient presents with hot swollen joint → Temperature + systemic features first → Septic arthritis vs gout triage decision

↓

🔴 Emergency — same day

Hot joint + fever (>38°C) + systemically unwell → same-day aspiration; septic arthritis until proven otherwise
Immunosuppressed patient + hot joint → same-day aspiration regardless of gout history
Sepsis with joint involvement (tachycardia, hypotension) → 999
Rapidly spreading cellulitis / lymphangitis → A&E same day
Acute urate nephropathy / tumour lysis → urgent nephrology

999 / same-day orthopaedics + aspiration

🟠 Urgent — 1–2 weeks

First episode without prior diagnosis → bloods + aspiration if uncertain
Polyarticular gout — first presentation → rheumatology within 2 weeks
Gout + AKI or worsening CKD → urgent renal function; nephrology
Severe tophaceous gout with ulceration → wound care + rheumatology

Urgent bloods + aspiration if uncertain

🟢 Routine — primary care

Known gout, afebrile, immunocompetent → colchicine or NSAID
Recurrent gout meeting ULT criteria → allopurinol after flare resolves
Review of established allopurinol → urate + renal function monitoring

Acute treatment + ULT planning

🔬 2 — Diagnostic Pathway

NICE NG219 ULT Criteria — Offer Allopurinol if:

✅ Multiple or troublesome flares

✅ Tophi present on examination

✅ Gout + CKD stages 3–5

✅ Chronic gouty arthritis

✅ Gout + chronic diuretic therapy

✅ Discuss ULT with everyone; press it in urate stones or young onset (<30: also refer)

⚠ NEVER stop established allopurinol in a flare; start new ULT 2–4 weeks after it settles (sooner only with anti-inflammatory cover if flares are frequent)

⚠ OFFER colchicine 500mcg OD prophylaxis while titrating to target (often up to 6 months)

Investigations — Timing and Targets

⏰ Serum urate: can be falsely low in a flare — if <360, repeat ≥2 weeks after it settles

✅ eGFR + FBC: Before allopurinol; annually on treatment

✅ Urine dipstick: Haematuria → renal imaging; proteinuria → CKD workup

✅ HbA1c + lipids: Metabolic syndrome screen at first presentation

🧬 HLA-B*5801: Screen before allopurinol in Han Chinese, Thai, Korean ancestry

🔬 Joint aspiration: Gold standard — indicated if diagnosis uncertain, fever, or immunosuppressed

📊 3 — Key Numbers

<360 µmol/L

Serum urate ULT target — standard patients

<300 µmol/L

Consider if tophi, chronic gouty arthritis or ongoing flares

Offer ULT

Multiple/troublesome flares, CKD 3–5, diuretics, tophi, chronic gouty arthritis

4–6 weeks

After flare → check serum urate (not during)

6 months

Typical colchicine prophylaxis duration (individualised)

50mg OD

Allopurinol starting dose in CKD (titrate slowly)

6mg max

Maximum colchicine per acute course

NEVER

Allopurinol + azathioprine = potentially fatal

HLA-B*5801

Screen before allopurinol in East/SE Asian ancestry

Losartan

Switch from thiazide — uricosuric + antihypertensive

MHRA

Febuxostat: use cautiously in major CVD; allopurinol first-line

38°C

Temperature threshold → same-day joint aspiration

💊 4 — Medication Decision & Choice

Acute Flare Treatment Ladder

First-line options (by comorbidity): Colchicine 500mcg BD–TDS (max 6mg/course); start within 12h; dose halve in eGFR 10–50; contraindicated in eGFR <10

or Naproxen 750mg then 250mg 8-hourly + PPI if indicated; or diclofenac 50mg TDS + PPI; avoid in CKD/HF/anticoagulants

or Prednisolone 30–35mg OD × 3–5 days (by preference or when others unsuitable); septic arthritis must be excluded first; check BG in diabetes

ULT and Medication Switches

First-line ULT: Allopurinol 50–100mg OD → titrate 4-weekly + colchicine 500mcg OD prophylaxis for 6 months

Alternative ULT: Febuxostat 80mg OD (→120mg) — by comorbidity/preference or if allopurinol unsuitable; MHRA: caution in major CVD; never with azathioprine

Thiazide switch: Bendroflumethiazide → Losartan 50mg OD; check eGFR + K+ at 1–2 weeks post-switch

Never: Allopurinol + azathioprine · Stop established allopurinol during flare · Colchicine in eGFR <10 · Febuxostat in CVD without risk discussion

⚠ 5 — Safety Netting & Follow-Up

Follow-up timeline

1–2 weeks: Flare resolution check; if persistent → reconsider diagnosis (septic arthritis?)

4–6 weeks: Serum urate baseline; eGFR + FBC; initiate allopurinol + colchicine prophylaxis

4–8 weeks on ULT: Urate on treatment; dose titration if above target

~6 months: Consider stopping colchicine prophylaxis if urate at target and flare-free (individualise)

Annual: Serum urate + eGFR + FBC; CVD risk (QRISK3); alcohol and lifestyle review

📌 URATES monitoring: Urate · Renal function · Alcohol · Tophi · Escalation · Statin/azathioprine interactions

🔬 6 — Monitoring & Red Flags

Drug	Monitor	Timing	Action threshold
Allopurinol	Serum urate; eGFR; FBC; skin rash	4 weeks after each dose change; 3 months; then annually	Urate above target → increase dose by 50–100mg; any rash → STOP immediately; eGFR deterioration → dose reduction; HLA-B*5801 positive → avoid
Colchicine (prophylaxis)	Flare frequency; GI tolerability; duration of prophylaxis	Review at 6 months — stop if urate at target + flare-free ≥3 months	Continued flares → ULT dose not yet at target; significant diarrhoea or muscle pain → stop and seek urgent advice; eGFR <10 → contraindicated
Febuxostat	Serum urate; LFTs; cardiovascular events	4 weeks post-start; LFTs at 3 months; annually	LFT >3× ULN → stop; cardiovascular event → reassess vs allopurinol switch; annual CVD risk review
Losartan switch	BP; eGFR; serum K+; serum urate	1–2 weeks after switch (and after dose increases); then 6-monthly	K+ >5.5 mmol/L → dose reduction; BP not controlled → titrate to 100mg; urate → expect 15–20% reduction

🚨 Red flags: Hot joint + fever >38°C → septic arthritis until aspiration proves otherwise; any rash on allopurinol → stop immediately (SJS/TEN risk); allopurinol + azathioprine = potentially fatal — check drug list at every prescription

🛡️ Safeguarding: Alcohol dependence may indicate domestic abuse or child neglect; AUDIT-C at every gout consultation; colchicine overdose risk — prescribe appropriate quantities; gout disability and social isolation — assess psychosocial impact

🎓

SCA Exam Quick Reference

SCA Consultation Blueprint

Tasks · Relating to Others · Global Skills · RAG guide

▼expand

🕐 12-Minute Consultation Flow — with Domain Scoring

0–2 min

Open + Characterise the Attack

"Tell me what's been happening — what's the pain been like and how did it start?"

Allow narrative to emerge: nocturnal onset, extreme tenderness, erythema, single joint. Confirm which joint, onset time, severity (allodynia?), prior episodes. Ask about fever / systemic illness — this is the critical triage question.

First 2 minutes establishes the diagnosis AND the triage decision. Fever present → entire management changes (septic arthritis pathway — A&E same day).

Global SkillsTasks

✗ No open question · ✗ Not asking about fever/systemic illness · ✗ Diagnosing gout before full history · ✗ Not counting previous episodes for ULT eligibility

2–5 min

Medication Review + ULT Eligibility + ICE

"Are you on any water tablets for blood pressure? Any aspirin? Any other medications including immunosuppressants?"

Identify thiazide diuretics (iatrogenic gout — losartan switch opportunity); determine ULT eligibility (multiple/troublesome flares, CKD 3–5, diuretics, tophi, chronic gouty arthritis); screen for azathioprine (potentially fatal with allopurinol).

ICE: "What do you think is causing these episodes?" / "Is there anything about treatment you're worried about?" / "What were you hoping we'd do today?"

TasksRelating to Others

✗ Not reviewing medications · ✗ Missing thiazide as gout cause · ✗ Not determining ULT eligibility · ✗ Not checking for azathioprine

5–7 min

Examination — Temperature First

"I'm going to take your temperature first — that's the most important single check. Then I'll examine the joint and check your ears and hands for any chalky deposits."

Temperature → rules out septic arthritis if afebrile; communicate result therapeutically ("temperature normal — reassuring, we can manage this here"). Examine tophi. BP if on antihypertensives. BMI / waist.

TasksGlobal Skills

✗ No temperature check · ✗ No tophi examination · ✗ Findings not communicated to patient · ✗ BP not checked if switching antihypertensive

7–10 min

Diagnosis + Treatment Plan

"What's happening is tiny sharp crystals — like microscopic needles — have formed in your joint from uric acid that's built up in your blood. That's causing the extreme pain."

Crystal mechanism. Colchicine prescribed today. Allopurinol deferred — explain why. Thiazide-to-losartan switch offered. Address allopurinol-flare concern proactively: "Allopurinol can cause a temporary flare — we prescribe colchicine alongside it for 6 months to prevent this."

TasksRelating to Others

✗ Starting allopurinol today · ✗ Not addressing allopurinol-flare concern · ✗ Missing thiazide switch · ✗ Telling patient diet alone will cure gout

10–12 min

Safety Nets + Lifestyle + Close

"If you develop a fever with a joint attack — go to A&E the same day. If you get a rash on the allopurinol — stop it immediately and call us."

Fever + hot joint = A&E (septic arthritis). Rash on allopurinol = stop immediately (SJS). Lifestyle: beer reduction specifically (not complete cessation); adequate hydration; gradual weight loss. Closing question.

TasksRelating to OthersGlobal Skills

✗ No fever safety-net · ✗ No rash safety-net · ✗ Generic lifestyle advice · ✗ Telling patient to stop drinking completely (unnecessary and demotivating) · ✗ No closing question

🔴🟠🟢 RAG Scoring — All 3 Domains

Tasks Domain

🟢

Septic arthritis excluded; colchicine prescribed correctly; allopurinol deferred with colchicine prophylaxis planned; NICE NG219 ULT criteria applied; thiazide-to-losartan switch; eGFR before ULT; fever and rash safety-nets explicit; urate timing explained

🟠

Septic arthritis mentioned but not explored; acute treatment correct but ULT timing wrong; colchicine prophylaxis omitted; thiazide identified but switch not offered; fever safety-net vague; allopurinol-flare concern not addressed

🔴

Allopurinol started during flare; no septic arthritis consideration; no medication review; no colchicine prophylaxis; no safety-nets; no ULT eligibility assessment; no renal function check

Relating to Others

🟢

ICE all three; crystal mechanism ("microscopic needles"); allopurinol-flare proactively addressed; diet limitation acknowledged; stigma destigmatised; shared decision making; closing question; pain severity acknowledged

🟠

ICE partially; crystal mechanism not explained; allopurinol-flare concern not raised; tells patient diet will cure it; no shared decision on ULT; no closing question

🔴

No ICE; no explanation; gout stigma reinforced; allopurinol prescribed without discussion; no empathy for pain; patient leaves not understanding the condition or plan

Global Skills

🟢

Open question; two-phase structure (acute vs ULT) clear; temperature communicated therapeutically; written information offered; closing question; consultation paced appropriately for a patient in severe pain

🟠

Targeted questions first; two-phase structure unclear; examination not communicated; no written information; no closing question

🔴

No open question; allopurinol started during flare without explanation; no examination communicated; no safety-nets; patient leaves confused about the plan

💬 Key Phrases — ICE, Diagnosis & Plan

Crystal mechanism (plain language)

"Tiny sharp crystals — like microscopic needles — have formed in your joint from uric acid that's built up in your blood. Those crystals cause the intense inflammatory reaction — that's why the pain is so extreme."

Allopurinol-flare — proactive address

"You're right that allopurinol can sometimes trigger a temporary flare when you first start it — as the uric acid drops, crystals already in the joint can shift. We prevent this by prescribing a low-dose anti-inflammatory alongside it for the first six months. Do not stop the allopurinol if this happens."

Diet limitation — honest framing

"Diet does play a role, and we'll talk about some changes that genuinely help — but for most people with gout, diet alone isn't enough to bring uric acid to where it needs to be. The medication does the heavy lifting."

Fever safety-net (critical)

"If you ever develop a temperature with one of these joint attacks — fever, chills, feeling genuinely unwell — go to A&E the same day. Don't wait for an appointment here. This is the most important thing I want you to remember."

Thiazide switch to losartan

"I want to suggest switching your blood pressure tablet from the water tablet to a different type called losartan — it controls blood pressure just as well, but it also has a small bonus of slightly lowering your uric acid."

Rash safety-net (allopurinol)

"If you develop any rash at all while on the allopurinol — stop the tablet immediately and contact us the same day. A rash can occasionally be the beginning of a serious skin reaction that needs urgent assessment."

🚫 9 Danger Zones — Instant Deductions

✗

Stopping established allopurinol during a flare, or starting it mid-flare without cover→ Keep established ULT going; start new ULT at least 2–4 weeks after the flare settles, or during frequent flares only with effective anti-inflammatory cover (NICE NG219)

✗

Not offering colchicine prophylaxis when starting ULT→ Offer colchicine 500mcg OD while titrating to target (often up to 6 months, individualised) to prevent initiation flares; failing to offer it is a clinical error and SCA deduction

✗

Not asking about fever and treating as gout without considering septic arthritis→ Temperature is the most important triage decision; fever + hot joint = same-day aspiration — this is the key safety-net in all gout presentations

✗

Not identifying the thiazide diuretic as a modifiable gout trigger→ Medication review is a core SCA task; thiazide for uncomplicated hypertension → switch to losartan ARB; missed in most gout SCA failures

✗

Prescribing allopurinol without checking eGFR first→ Allopurinol dose must be adjusted to renal function; standard dose in CKD causes allopurinol toxicity including hypersensitivity syndrome

✗

Not screening for allopurinol + azathioprine interaction→ Potentially fatal; allopurinol inhibits xanthine oxidase → azathioprine toxicity → bone marrow failure; always check drug list before every allopurinol prescription

✗

Telling the patient diet alone will cure gout→ Sets inaccurate expectations; most patients cannot reach serum urate target through diet alone; patients who believe this refuse ULT and continue having flares

✗

Not giving the fever / septic arthritis safety-net→ Medico-legally essential; documented in clinical negligence cases; temperature + hot joint = A&E same day — must be stated explicitly and specifically

✗

Prescribing febuxostat in CVD patient without discussing cardiovascular risk→ Current MHRA advice: use febuxostat cautiously in pre-existing major CVD; risk-benefit discussion must be documented; NICE: allopurinol first-line in major CVD

💊 Drug Quick-Pick by Scenario

Acute gout flare — afebrile, immunocompetent

→Colchicine 500mcg BD–TDS (max 6mg/course)

Start within 12h of attack for best effect. Dose halve if eGFR 10–50. Contraindicated in eGFR <10. Check statin + ciclosporin interactions.

Acute gout — NSAID option (normal kidneys, no GI/CV risk)

→Naproxen 750mg then 250mg 8-hourly + PPI (omeprazole 20mg)

Avoid in CKD (eGFR <30), HF, anticoagulants, active peptic ulcer. Always add PPI if patient over 45 years.

Acute gout — steroid option (others unsuitable, or by preference)

→Prednisolone 30–35mg OD × 3–5 days

Septic arthritis must be excluded first. Check blood glucose in diabetics. Avoid repeated courses.

ULT first-line — all patients meeting NICE NG219 criteria

→Allopurinol 50–100mg OD + colchicine 500mcg OD × 6 months

Start 2–4 weeks after the flare settles (or during frequent flares with cover). Titrate every 4 weeks. Target <360 µmol/L (<300 if tophi). HLA-B*5801 screen in East/SE Asian patients. NEVER with azathioprine.

ULT alternative — by comorbidity/preference or allopurinol unsuitable

→Febuxostat 80mg OD (→120mg) + colchicine prophylaxis

MHRA: use cautiously in major CVD — discuss risk-benefit. Never with azathioprine or mercaptopurine.

Gout + hypertension on thiazide diuretic

→Switch to Losartan 50mg OD (uricosuric ARB)

Reduces serum urate 15–20%. Equivalent BP control. Check eGFR + K+ at 1–2 weeks post-switch. Do NOT switch loop diuretics in heart failure.

⛔ Never do: stopping established allopurinol in a flare | allopurinol without offering colchicine prophylaxis | allopurinol + azathioprine | febuxostat in CVD without MHRA risk discussion | colchicine in eGFR <10 | NSAID in CKD/HF | prednisolone before septic arthritis excluded | diagnosing gout in febrile immunosuppressed patient without aspiration

Gout · GP Clinical Reasoning Framework v2 · NICE NG219 Gout (2022) · ACR/EULAR 2015 Classification Criteria for Gout · MHRA Drug Safety Update: febuxostat (current advice, superseding 2019) · BSR Guidelines on the Management of Gout

v3: Dual tailored summaries (Clinic + SCA) with visual algorithms · v2: Clinical stem · Open Q first · ICE in all modes · Psychosocial context (1E + 7G) · Lay language DDx (Step 5) · Safeguarding (Step 1) · Expectation management (7A) · SCA RAG checkpoints after every step · SCA Scorecard as standalone section

Teaching clinicians why each step matters — not just what to do · Always consult current SPC · Clinical judgement takes precedence over any framework · NICE NG219 (2022): allopurinol is first-line ULT; start 2–4 weeks after a flare settles and never stop it during a flare; offer colchicine prophylaxis while the ULT dose is titrated to target (usually 3–6 months); NEVER combine allopurinol with azathioprine

Gout

Red Flags — act before continuing history

Safeguarding Considerations — Consider in Every Consultation

🍺 Alcohol Use and Dependence

🏠 Domestic Abuse and Social Circumstances

👴 Older Adults and Frailty

💊 Medication Concerns and Self-Harm

🍺 Alcohol Culture and Social Context

🍽️ Diet and Food Access

😤 Stigma and Self-Blame

💼 Occupational Impact and Sick Leave

⚕️ Medication Reluctance and Health Beliefs

🏃 Physical Activity and Weight

Same-Day Hospital / Orthopaedics

Same-Day / 2-Week Assessment

Manage in Primary Care

Psoriatic Arthritis

Reactive Arthritis (Sexually Acquired)

Early Rheumatoid Arthritis

Septic Arthritis

Acute Urate Nephropathy (Tumour Lysis)

Validate — name their expectation

Explain — share your clinical reasoning

Negotiate — offer something today

Stigma and Shame

Occupational Disability

Impact on Family and Relationships

Long-Term Medication Acceptance

Understanding of the Condition

Self-Efficacy and Empowerment

1–2 weeks — Acute flare review

4–6 weeks — ULT initiation + blood results

4–8 weeks after ULT start — Serum urate + dose titration

6 months — Colchicine prophylaxis review + urate at target?

Annual review — Monitoring + CVD risk

Memory rule — Gout Monitoring: URATES

⚠ Three scenario-specific phrases — use these verbatim

Why safety-netting matters beyond clinical care

🎭 Patient actor brief — click to practise

Who you are

Hidden agenda

Symptoms if asked directly

Lifestyle + bonus details